Half-yearly Report
HgCapital Trust plc
Interim Results for the six months ended 30 June 2012
London, 23 August 2012: HgCapital Trust plc (“the Trustâ€), which provides
investors with a listed vehicle to invest in all private equity deals managed
by HgCapital, today announces its interim results for the six months ended 30
June 2012.
HgCAPITAL TRUST PLC CONTINUES TO DELIVER LONG TERM OUTPERFORMANCE
Summary performance for six months to 30 June 2012 and pro-forma results taking
into account three realisations since the period end detailed below
Pro-forma 30 June 2012 as reported
% Total return* Adjusted % Total return* Actual
NAV per share (diluted) +10.1% 1,166.9p +7.4% 1,138.3p
(basic) +11.5% 1,204.4p +8.4% 1,170.8p
Share price -6.1% 901.0p
FTSE All-Share Index +3.3%
Movement Movement
NAV +£36.5m £383.3m +£25.8m £372.6m
* Assuming reinvestment of all dividends
 +14.4% p.a. 10-year compound annual growth rate of the share price on a total
return basis vs.+6.1% p.a. from the FTSE All-Share Index on a total return basis
to 30 June 2012.
 Strong Sales and EBITDA growth from top 20 buyout investments of +11% and +12%
respectively over last 12 months to 30 June 2012.
 Three realisations agreed since the period end (SHL, Mercury Pharma and RPP1’s
UK Wind operating assets) with a total consideration of £69.1 million.
- Sale of SHL agreed, at a 3.1x investment multiple with cash proceeds of
£26.8 million.
- Sale of RPP1’s UK wind platform, at a 2.0x investment multiple will return
£5.9 million to the Trust
- Sale of Mercury Pharma agreed at a 4.1x investment multiple (potentially
rising to 4.3x), with a cash consideration of £35.4 million and further
potential proceeds of £1.0 million over the next 30 months.
 Pro-forma liquid resources post these transactions will be approximately £130
million (34% of pro forma NAV) with outstanding commitments of £179.1 million (47%
of pro-forma NAV).
Manager Outlook
 Despite the weak macro-economic environment across Western Europe we believe that
our investment strategy of identifying high quality growth companies in market niches
will continue to benefit the performance of our portfolio.
 We remain relatively cautious on new investment although within our sectors of
expertise we continue to find opportunities to acquire market leading businesses at
reasonable prices.
 As recently evidenced, we continue to see an active interest in acquiring a number
of our portfolio companies which may lead us to realise a number of our investments
over the next 18 months.
 Owning a portfolio of quality growth companies run by talented managers should
continue to build significant shareholder value over the medium-term.
Roger Mountford, Chairman of the Trust, commented:
“The Trust is well positioned, with a balance of assets that are steadily creating
value under HgCapital’s management and a pipeline of new investment opportunities.
The portfolio continues to deliver double digit revenue and profit growth year on year.
The Trust's record of rewarding long-term investors continues to justify investmentâ€.
- Ends –
The full Interim Results and a webcast describing the results are available at
http://www.hgcapitaltrust.com/.
For further details:
HgCapital
Nic Humphries (CEO, HgCapital) +44 (0)20 7089 7888
Roger Mountford (Chairman, HgCapital Trust plc)
Maitland +44 (0) 77 99 66 26 01
Rowan Brown
George Hudson +44 (0)20 7379 5151
About HgCapital Trust plc
HgCapital Trust plc is an investment trust whose shares are listed on the
London Stock Exchange. The Trust gives investors exposure, through a liquid
vehicle, to a portfolio of high-growth private companies, managed by HgCapital,
an experienced and well-resourced private equity firm with a long-term track
record of delivering superior risk-adjusted returns for its investors.
For further details, see www.hgcapitaltrust.com and www.hgcapital.com
Neither the contents of HgCapital’s website, HgCapital Trust’s website nor the
contents of any website accessible from hyperlinks on the websites (or any other
website) is incorporated into, or forms part of, this announcement.
HgCapital Trust plc announces that the interim report and accounts of the
Trust for the half-year ended 30 June 2012 have been published. The interim
report and accounts can be accessed via the Trust's website at
http://hgcapitaltrust.com/sites/default/files/HgTInterim2012.pdf
In order to meet the requirements of the Disclosure and Transparency Rules,
the full text of the interim report and accounts has been included below.
HgCapital Trust plc
INTERIM REPORT AND ACCOUNTS
30 June 2012
INVESTMENT OBJECTIVE
The objective of the Trust is to provide shareholders with long-term capital
appreciation in excess of the FTSE All-Share Index by investing in unquoted
companies.
The Trust provides investors with exposure to a diversified portfolio of
private equity investments primarily in the UK and Continental Europe.
References in this interim report and accounts to HgCapital Trust plc have
been abbreviated to `HgCapital Trust' or the `Trust'. HgCapital refers to the
trading name of HgPooled Management Limited and HgCapital LLP, who act as the
`Manager'.
PERIOD PERFORMANCE
NET ASSET VALUE (`NAV') £373 MILLION
The NAV (diluted) per ordinary share rose from £10.69 to £11.38 over the
period. An increase (on a total return basis) of +7.4%.
MARKET CAPITALISATION £287 MILLION
The ordinary share price fell from £9.70 to £9.01 over the period. A decrease
(on a total return basis) of -6.1%.
LONG-TERM PERFORMANCE - 10 TEAR TOTAL RETURN
14.4% p.a. - The compound annual growth rate of the HgCapital Trust plc share
price over the last 10 years.
£3,854 - How much an investment of £1,000 in HgCapital Trust plc ten years ago
would now be worth.*
An equivalent investment in the FTSE All-Share Index* would be worth £1,809.
*Assuming reinvestment of all dividends
THE PORTFOLIO
HgCapital Trust plc gives investors access to a private equity portfolio of
currently 32 companies, run by an experienced and well-resourced Manager that
makes investments in private companies across Northern Europe in the
Healthcare, Industrials, Services and TMT sectors.
An investment in HgCapital Trust plc primarily provides exposure to a
portfolio of fast growing companies. The top 20 buyout investments currently
account for 86% of the portfolio value. These companies have aggregate
revenues of £2.1 billion and profits of £0.5 billion.
In addition, the Trust has made a commitment to small-cap TMT deals, where the
Manager has many years of experience, through HgCapital's Mercury fund.
Finally, it also holds investments in the Manager's two renewable energy
funds.
+11% p.a. revenue growth - The average growth in revenues of the top 20 buyout
investments for the 12 months ended 30 June 2012.
+12% p.a. profit growth - The average growth in profits (EBITDA) of the top 20
buyout investments for the 12 months ended 30 June 2012.
10.6x EV/EBITDA multiple - The average valuation multiple used to value the
top 20 buyout investments at 30 June 2012.
3.4x Net debt/EBITDA - The average net debt/EBITDA multiple of the top 20
buyout investments at 30 June 2012.
CHAIRMAN'S STATEMENT
Strong trading in our portfolio of investments creates a sound platform for
value to be created and crystallised for the benefit of shareholders. The
Trust's record of rewarding long-term investors continues to justify
investment.
Performance in the first half
The Trust achieved a solid performance in the first half, with growth in the
diluted net asset value delivering a total return of +7.4%. This compares well
against a total return of +3.3% in the FTSE All-Share Index. The Trust's fully
diluted NAV per share was £11.38 at 30 June 2012, an increase of 69 pence per
share over the NAV per share of £10.69 at 31 December 2011, after the payment
of a 10 pence dividend.
The largest contributing factor in the increase in valuations in the portfolio
was the continuing strong trading performance of nearly all the Trust's
principal investments. Over the last twelve months, revenues of our top twenty
buyout investments grew by 11%, and their EBITDA grew by 12%. Solid growth at
these levels, with moderate leverage, can deliver very attractive returns to
private equity investors.
Realisations since 30 June 2012
Since the period end we have agreed the sale of the Trust's interests in SHL
(an Hg5 vintage investment), Mercury Pharma (formerly known as Goldshield,
which was an early Hg6 vintage deal) and the UK renewable energy platform's
operating assets held in the Manager's RPP1 fund. The sale price of SHL is
reflected in the NAV at 30 June but, on completion, proceeds from Mercury
Pharma and RPP1 will together add some £10.7 million to NAV and 28.6 pence per
share to NAV (fully diluted). Accounting for these transactions, the pro-forma
NAV of the Trust is £383.3 million and £11.67 per share (diluted). Available
liquid resources will be approximately £130 million following the completion
of all three sales.
SHL and Mercury Pharma both achieved strong growth in revenues and EBITDA over
the last year, and with good prospects for continuing growth created a very
sound platform for their realisation at above the Directors' valuation at
December 2011. However, these were by no means alone in achieving growing
sales and profits: nearly half of our top twenty buyouts reported revenue and
EBITDA growth above 10% p.a. and the majority of our investments have
continued to trade well in recent months, suggesting that there will be more
opportunities for value to be created for the benefit of the Trust.
The sale of RPP1's UK renewable energy platform's operating assets, comprising
three established windfarms, was the largest windfarm transaction in the
country for several years. Purchased by the asset management arm of Munich Re,
MEAG, as a source of long-term yield, this validates the fund's strategy of
developing projects that together form a portfolio meeting the investment
criteria of large institutional investors. Including earlier distributions,
this asset has returned twice its original investment and contributed a gross
IRR of 20% p.a.
Share price performance
At £9.01 (31 December 2011: £9.70) the share price was down 6.1% on a total
return basis. The discount against the then published NAV had increased to
around 15%, the highest it has been for many years. While there continues to
be plenty of interest in the Trust's shares, and few sellers, the high levels
of uncertainty in financial markets, especially arising from the woeful lack
of progress in resolving problems in the eurozone, have resulted in the
discounts on most private equity investment trusts drifting out.
I remind holders of the Trust's subscription shares that they will have only
one more opportunity, on 31 October 2012, to subscribe for new ordinary shares
at the price of £9.50 per share. There will then be one final opportunity to
exercise, on 31 May 2013, but the subscription price will rise by 75 pence to
£10.25 per share. Holders of subscription shares should note that under the
Trust's normal policy for payment of dividends, new ordinary shares issued as
a result of exercise of subscription rights in October 2012 will qualify for
the dividend to be paid in Spring 2013; new ordinary shares issued following
subscription on the exercise date in May 2013 will not qualify to receive that
dividend. To assist shareholders, I describe below the factors that affect the
level of dividend for the year.
If all the remaining subscription shares were exercised at £9.50 it would
raise new funds of £52.2 million for the Trust to deploy and should further
enhance the liquidity of the market in the Trust's shares.
Dividend
The Trust is managed with the objective of achieving capital growth, not to
deliver any target earnings or dividend. However, to maintain our investment
trust status the Trust is required to retain no more than 15% of the current
year's total income earned from investments.
Income from investments in the first half of the year benefited from the
revaluation of the portfolio at 30 June 2012. This, together with current
interest on loans to buyout investments, has resulted in a revenue return in
the first six months of 24.07 pence per ordinary share. However, shareholders
should understand that the valuation at 31 December 2012 may also affect
revenue returns available for distribution.
Reporting
The Board places great importance on the transparency and clarity of its
reporting. I hope that, since it was relaunched in late 2011, shareholders and
analysts have found the Trust's website, www.hgcapitaltrust.com, to be
informative and easy to use. I am pleased to report that in the awards run by
the Association of Investment Companies, both our annual report and our
website were selected as the best-in-class among specialist investment
companies.
Prospects
The portfolio of buyout investments continues to deliver double digit revenue
and profit growth year-on-year, despite economic headwinds, demonstrating that
value continues to be created. The portfolio has limited exposure to cyclical
businesses. Following the latest realisations the Trust is expected to have
available liquid resources, including its bank facility, totalling approximately
£130 million; we are approaching the point in our investment cycle when the assets
of the Trust are most fully invested, putting shareholders' funds to work in the
creation of value. Recent sales show that both financial investors and corporate
buyers have access to funding for the acquisition of sound, growing businesses.
In addition to the recent sales of buyout investments, it is notable that the
portfolio of renewable energy projects has also matured to the point where
some are ready for sale to financial investors looking for long-term, steady
yield and trade buyers seeking to grow their exposure to renewable energy
assets. There continues to be uncertainty around the Spanish government's
proposals for taxation of renewable energy revenues but, following provisions
that we believe are prudent, the Trust's residual exposure represents less
than 1.7% of NAV.
As a whole, the Trust is well positioned, with a balance of assets that are
steadily creating value under HgCapital's management and a pipeline of new
investment opportunities, especially in HgCapital's traditional area of
expertise in smaller TMT deals, through their new Mercury fund. There remains
scope over the next year for two or three more acquisitions under the Trust's
commitment alongside the Manager's Hg6 fund. The Board believes that the
Trust's record of rewarding long-term investors continues to be justified.
Roger Mountford
Chairman
22 August 2012
INTERIM MANAGEMENT REPORT & RESPONSIBILITY STATEMENT
Interim management report
The important events that have occurred during the period under review are set
out in the Chairman's statement and in the Manager's review, which also
include the key factors influencing the financial statements.
The Directors do not consider that the principal risks and uncertainties have
changed since the publication of the annual report for the year ended 31
December 2011. A detailed explanation of the risks summarised below can be
found on page 81 of the annual report which is available at
www.hgcapitaltrust.com.
Performance risk
The Board is responsible for deciding the investment strategy to fulfil the
Trust's objectives and for monitoring the performance of the Manager. An
inappropriate strategy may lead to poor performance.
Regulatory risk
The Trust operates as an investment trust in accordance with Sections 1158 and
1159 of CTA 2010. As such, the Trust is exempt from corporation tax on any
capital gains realised from the sale of its investments so the loss of
investment trust status would represent a significant risk to the Trust.
Operational risk
In common with most other investment trust companies, the Trust has no
employees. The Trust therefore relies upon the services provided by third
parties and is dependent upon the internal control systems of the Manager and
the Trust's other service providers.
Financial risks
The Trust's investment activities expose it to a variety of financial risks
that include valuation risk, liquidity risk, market price risk, credit risk,
foreign exchange risk and interest rate risk.
Liquidity risk
The Trust, by the very nature of its investment objective, invests in unquoted
companies, and liquidity in their securities can be constrained, potentially
making the investments difficult to realise at, or near, the Directors'
published valuation at any one point in time.
Responsibility statement
The Directors confirm that to the best of their knowledge:
- The condensed set of financial statements has been prepared in accordance
with the Statement on Half-yearly Financial Reports issued by the UK
Accounting Standards Board and gives a true and fair view of the assets,
liabilities, financial position and profit of the Trust;
- The interim management report (incorporating the Chairman's Statement and
the Manager's Review of the Period) includes a fair review of the information
required by:
(a) DTR 4.2.7R of the Disclosure and Transparency Rules, being an indication
of important events that have occurred during the first six months of the
financial year and their impact on the condensed set of financial statements;
and a description of the principal risks and uncertainties for the remaining
six months of the year; and
(b) DTR 4.2.8R of the Disclosure and Transparency Rules, being related party
transactions that have taken place in the first six months of the current
financial year and that have materially affected the financial position or
performance of the Trust during that period; and any changes in the related
party transactions described in the last annual report that could do so. There
were no related party transactions during the period.
This half-yearly financial report was approved by the Board of Directors on 22
August 2012 and the above responsibility statement was signed on its behalf by
Roger Mountford, Chairman.
LONG-TERM PERFORMANCE RECORD
HgCapital Trust plc's share price has delivered significant outperformance
against the FTSE All-Share Index over the long-term.
HISTORICAL TOTAL RETURN* PERFORMANCE
Six
months to
30 June Seven
2012 One year Three Five years years Ten years
% % p.a. years % p.a. % p.a. % p.a.
% p.a.
Net Asset Value (diluted) 7.4 1.7 11.3 8.7 12.8 14.5
Net Asset Value (basic) 8.4 1.8 12.3 9.3 13.3 14.8
Share price (6.1) (20.1) 6.9 4.1 10.2 14.4
FTSE All -Share Index 3.3 (3.1) 13.8 0.4 5.4 6.1
Share price outperformance (9.4) (17.0) (6.9) 3.7 4.8 8.3
per annum
against the FTSE All -Share
Index
THE TRUST'S INVESTMENT OBJECTIVE AND INVESTMENT POLICY
INVESTMENT OBJECTIVE
The Investment Objective of the Trust is to provide shareholders with
long-term capital appreciation in excess of the FTSE All-Share Index by
investing in unquoted companies. If the Board proposes to amend the Trust's
Investment Objective, it will seek the approval of shareholders in a general
meeting.
INVESTMENT POLICY
The principal policy of the Trust is to invest in a portfolio of unlisted
companies that are expected to grow organically or by acquisition. Any
material change to the Trust's Investment Policy will be made only with the
approval of shareholders in a general meeting.
The Trust's maximum exposure to unlisted investments is 100% of the gross
assets of the Trust from time to time. At the time of acquisition, no single
investment will exceed a maximum of 15% of gross assets.
The Trust may invest in assets other than companies, so long as the Manager
believes that its expertise in private equity investment can be profitably
applied. The Trust may invest in unlisted funds up to a maximum at the time of
acquisition of 15% of gross assets. The Trust may invest in other listed
investment companies, including investment trusts, up to a maximum at the time
of acquisition of 15% of gross assets.
The Trust may invest its liquid funds in government or corporate securities,
or in bank deposits, in each case with an investment grade rating, or in
managed funds that hold investments of a similar quality.
Range and diversification
The Trust invests primarily in companies whose operations are headquartered or
substantially based, or which serve markets, in Europe. The Trust invests in
companies operating in a range of countries, but there is no policy of making
allocations to specific countries or markets. The Trust invests across a range
of sectors, but there is no policy of making allocations to sectors.
Gearing
Underlying investments or funds are typically leveraged to enhance value
creation, but it is impractical to set a maximum for such gearing. The Trust
may over-commit to invest in underlying assets in order to maintain the
proportion of gross assets that are invested at any time. The Trust has the
power to borrow and to charge its assets as security. The Articles currently
restrict the Trust's ability to borrow no more than, broadly, twice the
aggregate of the Trust's paid up share capital and reserves (without
shareholder approval).
Hedging
The Trust may use derivatives to hedge its exposure to interest rates,
currencies, equity markets or specific investments for the purposes of
efficient portfolio management.
RATIONALE AND BUSINESS MODEL
The Board has a clear view of the rationale for investing in private equity
through an investment trust and this informs its decisions on the operation of
the Trust and the evolution of the Board's Business Model.
RATIONALE
The Board believes that there is a convincing rationale for investing in
well-researched private businesses where there is potential for growth in
value, especially where the Investment Manager and the management of the
business can work together to implement strategic or operational change. These
can result in higher rates of growth in sales and enhanced profits, offering
investors capital gains on realisation.
Many large institutional investors have been making an allocation to private
equity funds for decades, each time committing to a 10-12 year closed end
fund, investing time to select a manager and negotiate complex and lengthy
limited partnership agreements, and then assuming the burdens of
administration, monitoring and accounting that these vehicles impose. In
return, the best managers have delivered better performance than most
investors have received from their listed equity, bond, hedge fund and
property portfolios. This long term commitment may not be practical for
smaller institutions, wealth managers, funds and private individuals that
intend to de-risk over time. As an alternative, these investors can gain
access to the private equity ownership model by buying shares in the Trust. As
an investment trust, it has an independent Board and is committed to
transparent and regular reporting, and the Trust is well covered by published
research. The Trust's shares are listed on the London Stock Exchange, where
they are freely tradeable.
BUSINESS MODEL
Working within the constraints of the Trust's Investment Policy, the Board and
the Manager have together developed a Business Model, which is kept under
regular review. The Business Model evolves as market conditions change and new
opportunities appear.
Asset class
The Trust invests directly into special purpose limited partnerships, that
invest on its behalf in unquoted businesses in the UK and Continental Europe
alongside other institutional clients of HgCapital, an experienced private
equity manager. The Trust is not a fund of funds and does not invest in other
managers' funds. This provides greater transparency for the Board and
shareholders in the Trust and avoids the double level of fees inherent in a
fund of funds.
Most of the Trust's investments are held through partnerships of which it is
the sole limited partner and which invest alongside pooled funds managed by
HgCapital (currently its Hg6 fund). The Trust invests on the same terms as
institutional investors. The Trust normally acquires 15% of the interest in
each business acquired by HgCapital on behalf of its clients.
The Manager is organised in investment teams that focus on business sectors
that the Manager researches in depth. The Manager does not make top-down
allocations to these sectors or to particular countries; the balance between
sectors and countries may change as investment opportunities appear and
portfolio companies are sold.
The Board of the Trust decides, after consultation with the Manager, on the
timing, amount and terms of each commitment it makes to invest in or alongside
any of the Manager's funds. Such commitments are normally drawn down over five
years as investment opportunities arise. The Board agrees each commitment at a
level it believes the Trust will be able to fund from its own resources or
from temporary borrowing. However, to protect the Trust from the risk of being
unable to fund any drawdown under its commitment the Board has negotiated a
right to `opt-out', without penalty, of any HGT 6 LP investment where certain
conditions exist (see note 12 to the financial statements).
In addition, the Trust has invested in renewable power generating projects, an
area where the Manager has developed its skills and built a specialist team.
This sector provides the Trust with an element of diversification, as it has
fundamentally different drivers of risk and return, and the profile of its
cash returns will complement those from buyout investments. In this sector, it
is advantageous to the Trust to participate with other institutional clients
of HgCapital as limited partners in HgCapital's two renewable energy funds.
Cash and borrowing
The Board and the Manager agree that prudent use of borrowing to fund
acquisitions can increase diversification within the portfolio and increase
rates of return to shareholders. Businesses in the underlying portfolio are
acquired with the benefit of bank borrowing at levels that can be serviced
from the cash flows generated within that business. The Board does not
currently see any advantage in using a further level of structural borrowing
by the Trust, as this would add risk without any certainty of enhancing
returns.
The Trust has a bank facility on which it can draw to meet short-term needs,
for example, between making an investment and receiving the proceeds from a
realisation. At certain points in the investment cycle the Trust may hold
substantial cash awaiting investment, which it holds in bank deposits or
invests in short-dated government bonds.
If there appears to be surplus capital and conditions for new investment
appear to be unfavourable, the Board will consider returning capital to
shareholders, probably through the market purchase of shares.
Hedging
The Trust offers exposure to a range of businesses operating in the UK, the
eurozone and the Nordic region. The Trust does not strategically hedge
investments back into sterling. From time to time, the Manager may use
derivatives approved by the Board to hedge tactically with the object of
protecting the anticipated sterling value of proceeds from realising
investments in other currencies.
Comparator
For most shareholders, their investment in the Trust represents a small
allocation of funds that would otherwise be invested in UK equities. The
Manager's aim is to achieve returns in excess of the FTSE All-Share Index over
the long term but is not intended to reflect movements in the Index. To assess
the Manager's performance relative to other private equity managers, the Board
regularly compares the Trust's NAV and share price performance against a
basket of peers listed on the London Stock Exchange and against the UK and
pan-European indices of listed private equity companies published by LPX.
Priorities as a listed investment company
As the rationale for the Trust is to provide investors with a way to invest in
an illiquid asset class, through a liquid listed vehicle, the Board has a
number of priorities including: retaining the status of an investment trust;
maintaining a liquid market in its shares; providing shareholders with
transparent reports on the underlying portfolio; adopting prudent valuations;
and avoiding adding risk at the Trust level.
Valuation
The Board reviews the values of each of its investments in fund limited
partnerships after considering, for the underlying investments held by the
funds, the following: analytical and performance data; the valuations prepared
by the Manager; and the Manager's valuation process. The Manager's valuations
are carried out in accordance with the International Private Equity and
Venture Capital (`IPEV') Valuation Guidelines, September 2009 edition. Further
information can be found at www.privateequityvaluation.com.
NAV and trading in the Trust's shares
The Board values the portfolio and publishes the Trust's NAV as at 30 June and
31 December. Each month, following these valuations, the NAV figure is
published after adjustment for realisations and movements in foreign exchange
and the market prices of any listed securities.
The Trust's shares trade on the London Stock Exchange at prices that are
independent of the Trust's NAV but reflect the NAV and expectations of future
changes in it. The shares have traded at a discount to the NAV and at times at
a premium to it. The Board has not attempted to manage any discount through
repurchase of shares, which it believes usually has only temporary effect.
The Board believes that discounts to NAV are minimised through consistent
long-term returns, transparent reporting, rigorous valuation and avoidance of
risk at Trust level.
Dividends
The Board does not structure the Trust's balance sheet or underlying
investments in order to deliver any target level of dividend. To maintain the
Trust's status as an investment trust, annual net revenue return retained,
after dividend distributions in respect of that financial year, may not exceed
15% of the annual total income earned from investments. The level of the net
revenue return varies from year to year according to the level of the Trust's
liquid funds and the short-term interest rates that can be earned on them, and
the structure of buyouts held at the time; net revenue return is also affected
by the valuation of accrued but unpaid interest on loans to investee
companies. Accordingly, dividends may vary from year to year. Where possible,
the Trust has elected to `stream' its income from interest-bearing investments
as dividends that will be taxed in the hands of shareholders as interest
income; this reduces the tax charge payable by the Trust.
THE MANAGER
HgCapital is a private equity investor focused on the European middle market.
Its business model combines sector-specific thematic investing with dedicated
portfolio management support. HgCapital invests primarily in growth companies
in expanding sectors via leveraged buyouts and in renewable energy generating
projects across Europe.
HgCapital's vision is to be the most sought after private equity manager in
Europe, being a partner of choice for management teams and renewable power
developers, so as to produce consistent top quartile returns for our clients
and a rewarding environment for our staff.
References in this interim report and accounts to the `portfolio',
`investments', `companies' or `businesses', refer to a number of primary
buyout investments, held indirectly by the Trust through its direct
investments in fund limited partnerships (HGT LP and HGT6 LP and HgCapital
Mercury D LP) of which the Trust is the sole limited partner; direct
investments in secondary buyout investments in HgCapital's 6 fund through
HgCapital 6 E LP (`Hg6E'), in which the Trust is a limited partner, and direct
investments in renewable energy fund limited partnerships (HgRenewable Power
Partners LP (`RPP1') and HgCapital Renewable Power Partners 2 C LP (`RPP2')),
of which the Trust is a limited partner.
INTRODUCTION TO THE MANAGER
HgCapital began life as Mercury Private Equity (MPE), the private equity arm
of Mercury Asset Management plc, a long-established, listed, UK-based asset
management firm. Mercury was bought by Merrill Lynch in 1997 and, in December
2000, MPE negotiated its independence as HgCapital and became a fully
independent firm, wholly owned by its partners. HgCapital has progressively
invested in and strengthened its business over the years to establish a
significant competitive advantage.
With nearly 100 employees in two investment offices in the UK and Germany,
HgCapital has assets under management of £3.8 billion serving a range of
highly regarded institutional investors, including private and public pension
funds, charitable endowments, insurance companies and family offices.
HgCapital's largest client is HgCapital Trust plc. Established in 1989, the
Trust appointed HgCapital as its Investment Manager in 1994. It offers
investors a liquid investment vehicle, through which they can obtain an
exposure to a diversified portfolio of private equity investments with minimal
administrative burdens, no long-term lock-up or minimum size of investment,
and with the benefit of an independent board.
THEMATIC INVESTMENT
HgCapital's five dedicated sector teams combine the domain knowledge and
expertise of a trade buyer - giving them superior credibility and the ability
to make quick decisions - with the flexibility of a financial investor,
leading to high conversion rates on deals we like.
This deep sector focus is channelled through a rigorous research-based
approach and disciplined thematic investment processes, through which the most
attractive segments of the European mid-market can be systematically
identified and then repeatedly invested in, optimising deal flow and improving
returns.
Following each investment, HgCapital's specialist portfolio management team
works to protect and enhance value, driving clear strategies for growth, and
managing a realisation that adds further value.
With substantial resources and a structure that focuses on delivering value,
HgCapital has the tools and ability to succeed consistently.
THE MANAGER'S STRATEGY AND TACTICS
Middle-market focus
HgCapital primarily focuses on middle-market buyouts with enterprise values of
between £20 million and £500 million and renewable power generating projects
using proven technologies. The middle market offers a high volume of companies
with proven financial performance and defensible market positions.
These companies are small enough to provide opportunities for operational
improvement, yet large enough to attract quality management and to offer
multiple exit options across market cycles.
European focus
HgCapital primarily focuses its buyout investments in the UK, Germany and the
Nordic Region, as well as Switzerland, Italy and Benelux.
Our renewable energy investments are focused on the British Isles, the Nordic
region and Spain.
All investments are managed by specialist, dedicated sector and portfolio
management teams located in London and Munich who work with a common purpose
and culture, applying consistent processes.
Clear investment criteria
HgCapital applies a rigorous and commercial investment approach when
evaluating all investment opportunities. Our objective is to complete the most
attractive investments rather than be constrained by a top-down asset
allocation.
For buyouts, HgCapital seeks companies with protected business models and
predictable revenues, which offer a platform for growing market share or have
the potential for significant performance improvement. HgCapital targets
situations where the Manager's specialist knowledge and skills can make a real
difference in supporting management to grow industry champions.
Broad coverage
HgCapital's dedicated sector teams provide investors with access to the
substantial majority of private equity activity within their target size range
and across their chosen geographies.
A full description of the Manager and its key staff is available on
www.hgcapital.com
Active portfolio management
Our sole objective is to ensure that all businesses in which we invest
maximise their long-term potential and reward all of their stakeholders. As a
result, HgCapital typically invests as the lead, majority shareholder and
appoints HgCapital executives to the companies' boards to assist each firm in
applying active, results-oriented corporate governance.
HgCapital professionals support the management of our portfolio companies to
develop, execute and monitor value enhancement strategies for each business.
Accordingly, HgCapital is in a position to review the performance of all of
its investments, identify quickly any issues that demand attention and ensure
that appropriate action is taken.
Deep resources
Our practice of employing specialisation - both in investment selection and
portfolio management - places significant demands on our time. Accordingly, we
have built a deeply resourced business employing nearly 100 staff, including
55 investment professionals.
Investing in businesses, many of which have a global footprint and which are
located across Europe, requires time and, of course, a deep understanding of
local cultures. Accordingly, our people come from around the globe including
ten Western European countries. Our partners have, on average, 15 years'
experience in private equity management.
LOCATION OF PRINCIPAL INVESTMENTS BY NUMBER AT 30 JUNE 2012:
Buyout Investments
Nordic Region: 4
UK: 14
Germany: 5
Benelux: 1
Switzerland: 1
Italy: 1
Renewable Energy Assets
Nordic Onshore Wind: 3
UK Onshore Wind: 7
Irish Onshore Wind: 1
French Onshore Wind: 2
Spanish Mini-Hydro: 2
Spanish Solar: 7
MANAGER'S REVIEW OF THE PERIOD
Summary
During the first half of the year, the diluted NAV per share increased by 7.4%
on a total return basis with the NAV rising from £346.8 million to £372.6
million. This was driven by a combination of strong earnings growth in the
underlying portfolio, improved ratings for some companies and continued
deleveraging. Total share price return declined by 6.1% over the period,
primarily reflecting a weak European economic environment and cautious market
sentiment to private equity.
As anticipated, new investment activity was subdued following the large number
of acquisitions made in 2010 and 2011, where the emphasis has been on bedding
in these companies and looking for value-enhancing bolt-on acquisitions.
In the period, we completed one new buyout investment in the Industrials
sector, with the acquisition of Qundis in Germany, a provider of sub-metering
devices and services. This investment totalled £76.8 million with the Trust's
share being £11.5 million. In addition to this acquisition, further
investments have been made within our existing portfolio (Voyage, Sporting
Index and Casa Reha) totalling £3.6 million. Further investment was also made
into renewable energy opportunities bringing the total investment by the Trust
in the six months to £19.7 million (please see below for a full breakdown of
these). During the period, £8.1 million was returned to the Trust from
investments.
Our top 20 buyout investments, which represent 86% of the portfolio value,
grew solidly in the last twelve months, recording average growth in revenue
and EBITDA of over 11% and 12% respectively.
At 30 June, the Trust had available liquid resources (including a debt
facility of £40 million) of £71.8 million. Following the completion of the
sale of SHL, Mercury Pharma and RPP1's UK Onshore windfarms, the Trust will
have approximately £130 million in available liquid resources. Outstanding
commitments to HgCapital funds amounted to £179.1 million.
Further details on these realisations are provided below.
Performance
Share price performance over the year has been disappointing. It remains our
belief that listed private equity funds are better measured over periods of
three, five, and ten years consistent with the long-term nature of private
equity investment in generating returns for clients.
Over three years, the share price of the Trust (on a total return basis) has
underperformed against the FTSE All-Share Index by 6.9% p.a., over five years
it has out-performed by 3.7% p.a., and over ten years by 8.3% p.a., net of all
costs. £1,000 invested in June 2002 would be worth £1,809 in June 2012 if
invested in the FTSE All-Share Index and £3,854 if invested in the Trust.
The growth in NAV per share is a lead indicator and driver of share price
performance over the long run: during the past six months it has risen by 7.4%
(total return on a diluted basis); this follows a period of relatively flat
NAV growth over the preceding 12 months, reflecting at that time both the
relative immaturity of the portfolio and some early write downs, where several
investments performed below our expectations.
Trading performance
The top 20 buyout companies, grew revenues by 11% and EBITDA by 12% over the
last twelve months to 30 June 2012, comfortably exceeding the growth in
nominal GDP. A number of our portfolio companies are investing in longer term
growth initiatives, such as product innovation or international expansion, and
as such we are yet to see the operational leverage we expect.
Average net margins of 25%, healthy growth rates and good market positions
indicate that these companies have, for the most part, been robust. They are
managed by talented and committed managers with a large proportion of their
net worth invested in the companies they lead and manage.
Nearly 90% of the top 20 buyouts by value increased revenues over the course
of the year to 30 June 2012. Close to half of these saw double-digit profit
growth year-on-year with companies such as Mercury Pharma, SHL, ATC and Group
NBT all performing strongly over the period.
As previously reported, a continued theme is weak trading at those companies
with a direct exposure to the consumer sector - such as Americana and Teufel -
who are experiencing a challenging environment and a decline in profits
year-on-year.
Valuation and Gearing Analysis
The portfolio is valued consistently from year to year, applying the IPEV
Valuation Guidelines. Our valuation of each company has produced an average
EBITDA multiple for the top 20 buyout investments of 10.6x EBITDA, slightly up
from the year-end (December 2011: 10.2x).
We continue to take a considered and prudent approach in determining the level
of maintainable earnings to use in each investment valuation. For June
valuations, the majority of the portfolio is valued using historic earnings,
unless we anticipate that the outlook for the full year 2012 is likely to be
lower than the previous year, in which case we will use forecast earnings.
In selecting an appropriate multiple to apply to the company's earnings, we
look for a basket of comparable companies primarily from the quoted sector,
but where relevant and recent, we will also use private M&A data.
The portfolio continues to reduce leverage as profits grow and the companies
pay down debt. The average debt/EBITDA multiple of the top 20 investments fell
from 4.0x to 3.4x in the six months to 30 June 2012.
Fair value classification*
53% Earnings
16% Price of recent investment
12% Written down
10% Net assets
8% Sales proceeds
1% Other
* Percentages are based on fixed assets (excluding hedges) and accrued
interest and are shown by value
Balance Sheet
Over the period the net assets of the Trust increased by £25.8 million from
£346.8 million to £372.6 million.
Attribution analysis of current year Revenue Capital Total return
movements in NAV return return
Opening NAV as at 1 January 2012 10,017 336,815 346,832
Dividends paid (3,182) - (3,182)
Proceeds from exercise of subscription - 40 40
shares
Gross revenue 12,781 - 12,781
Government securities realised and - (63) (63)
unrealised net losses
Realised capital proceeds from investment - 589 589
portfolio in
excess of 31 December 2011 book value
Net unrealised capital appreciation of - 23,340 23,340
investment portfolio
Expenditure and taxation (1,642) - (1,642)
Investment management costs:
Priority profit share - current year (3,536) - (3,536)
charge
Priority profit share - net loan 58 (58) -
allocation
Carried interest - (2,522) (2,522)
Closing NAV as at 30 June 2012 14,496 358,141 372,637
REALISED AND UNREALISED MOVEMENTS IN INVESTMENT PORTFOLIO (INCLUDING INTEREST)
FOR THE SIX MONTHS ENDED 30 JUNE 2012
Investment name and Net unrealised Realised proceeds in excess
ranking within appreciation/(depreciation) of 31 December 2011
investment portfolio at 30 of investments £'m book value £'m (includes
June 2012 gross revenue)
Mercury Pharma (3) 10.2 -
SHL (2) 5.7 -
Visma (1) 4.9 0.2
Voyage (14) 3.8 -
JLA (10) 3.0 -
Achilles (7) 3.0 -
Sporting Index (18) 2.2 -
Lumesse (6) 1.8 -
Other 1.2 0.6
Atlas (22) 1.3 -
KVT (24) 1.2 -
ATC (8) 1.2 -
Frösunda (15) 1.1 -
Casa Reha (25) (1.4) -
SimonsVoss (16) (1.7) -
RPP1 and RPP2 (1.7) -
Over the period, the NAV of the Trust increased by 7.4% from £346.8 million to
£372.6 million. There were two main drivers of this movement: firstly, it can
be attributed to the revaluation of the unquoted portfolio (+£23.3 million),
driven by strong trading performance; and secondly, income net of expenses
from the underlying portfolio and gilts (£11.1 million).
During the period, the value of the unrealised portfolio increased by £48.3
million. This change can be attributed to a number of factors: the increase of
£12.5 million from acquisitions and disposals; growth driven by strong trading
performance (+£18.1 million); the reduction of external debt from cash flow
generated by the portfolio (+£5.0 million); an increase in ratings during the
period (+£16.6 million); and adverse foreign exchange movements accounted for
a negative £3.8 million of unrealised movements in the portfolio.
OUTSTANDING COMMITMENTS
Fund Original Outstanding Outstanding
Commitment commitments commitments
Vintage £' million as at 30 as at 31
June 2012 December 2011
£' million %of NAV £' million %of NAV
HGT 6 LP (1) 2009 285.0 78.2 21.0% 85.9 24.8%
HgCapital 2011 60.0 58.5 15.7% 59.0 17.0%
Mercury D LP
Hg RPP2 C LP 2010 36.1(4) 23.1 6.2% 27.2 7.8%
HGT LP pre-2009 120.0 14.8 4.0% 17.1 4.9%
(Hg5 vintage)
HgCapital 6 E LP(2) 2009 15.0 4.1 1.1% 4.7 1.4%
Hg RPP LP 2006 19.5(3) 0.4 0.1% 1.2 0.3%
Total 179.1 48.1% 195.1 56.2%
Liquid resources 31.8 8.6% 53.5 15.4%
Bank facility 40.0 10.7% 40.0 11.5%
Total available 71.8 19.3% 93.5 26.9%
liquid resources
Net outstanding 107.3 28.8% 101.6 29.3%
commitments less
available liquid
resources
(1)HgCapital Trust plc has the benefit of an investment opt-out
provision in its commitment to invest alongside HgCapital 6, so that
it can opt out of a new investment without penalty should it not have
the cash available to invest.
(2)Partnership interest acquired during 2011.
(3)Sterling equivalent of €21.6 million.
(4)Sterling equivalent of €40.0 million.
Since the period end, adjusting for the realisations of SHL, Mercury Pharma
and the RPP1 fund's UK onshore wind operating assets, available liquid
resources will be approximately £130 million (34% of pro-forma NAV).
Portfolio of Investments
The Manager's strategy is to invest in five sectors, four of them by way of
buyouts of businesses (representing 93.2% of the portfolio by value at 30 June
2012). Investment in the fifth sector, renewable power generation (6.8%), is
made into projects through RPP1 and RPP2.
Buyout portfolio
As at 30 June 2012, the Trust's buyout portfolio comprised of 32 investments,
including a small number of residual interests in companies we had sold, which
were mostly valued at, or close to, zero. The Trust held investments, included
above, which had performed poorly and been written down to zero in previous
periods. This report covers only those companies with material value.
TMT represented 51% of the total primary buyout portfolio (57% at 31 December
2011). The majority of this value was represented by companies that are all
users of technology, rather than developers of technology with the associated
frequent challenges of new product development. The common themes that run
through each one are highly visible revenues, strong market positions and
strong cash conversion that permits debt repayment, whilst the businesses
expand and grow.
Visma, Teamsystem and IAS are providers of business software and services in
the Nordic region, Italy and UK respectively. These businesses benefit from
high recurring revenues, a very large and diversified customer base and they
continue to grow through a combination of organic growth and acquisitions.
Lumesse, the leading European provider of strategic HR software, has seen
continued strong demand for its products, leading to outperformance of
recurring software revenues. However, a change in product mix and economic
circumstances have resulted in weaker consulting revenue growth.
Achilles and Epyx, two electronic market place investments, continue to grow
strongly, delivering double digit growth year on year.
Group NBT, an internet domain name manager and online brand protection service
provider, is trading well and during the first six months of our ownership has
made a small acquisition in the Swedish market and most recently has sold the
non-core managed hosting business to a trade buyer.
Manx Telecom is the incumbent integrated fixed and mobile telecom operator on
the Isle of Man. It continues to trade solidly and has generated cash ahead of
expectation, reducing its debt each year.
ISG, a software provider to the UK's legal and not-for-profit sectors, was a
new investment made at the end of 2011 and its focus is on delivering
operational improvement.
Services investments represented 19% of the primary buyout portfolio (18% at
31 December 2011).
SHL, the global leader in talent management, has been sold since the period
end to a US trade buyer, The Corporate Executive Board Company, for $660
million.
ATC, a dutch fiduciary services business acquired in early 2011, has delivered
a strong trading performance since acquisition with double digit profit growth
and strong cash generation.
JLA, a provider of equipment, finance and maintenance to laundries had a
disappointing 2011, recording a flat level of profits compared with the
previous year. The new management team and innovative sales initiatives have
led to strong accelerated growth over the past 12 months.
Healthcare represented 17% of the primary buyout portfolio (14% at 31 December
2011). We are invested in two areas: long-term care where the payer risks are
low, with a preference for specialist care of people with acute disabilities;
and low cost pharmaceuticals.
We own long-term care assets in the UK, Germany, Sweden and Finland. In the
UK, the Government's fiscal consolidation translates into a reduction in fees
that local authorities and social services will pay for care, which has
resulted in a squeeze on margins.
Voyage, which has a more defensible business model, has managed to maintain
profits, repay debt and make an acquisition of Solar Care at an attractive
price. Improved ratings and the positive impact of the acquisition have led to
an increase in our book value.
In Germany, labour shortages have increased labour costs and squeezed margins.
Casa Reha has maintained earnings through opening new homes, of which five are
scheduled to open in 2012 and that should lead to an acceleration in growth.
At Frösunda, based in Sweden, a poorly executed acquisition programme, which
coincided with an operational improvement project, damaged margins and
revenues, leading to a reduction in the holding value. The business has now
stabilised and we are working with the new management team to improve the
performance of the business.
Our Finnish investment, Mainio Vire, has traded to plan and four new homes
have been opened during the period. The investment continues to be marked down
in value as the premium we paid to obtain this platform company has not yet
been recouped from expected synergies arising from further acquisitions and
organic growth.
Mercury Pharma, a pharmaceutical company, has continued to see strong growth
in its core business after selling, as planned, a weak and declining consumer
business. It has seen earnings rise and debt reduce rapidly. It was announced
in August that we have agreed the sale of Mercury Pharma. More detail can be
found below.
Industrials represented 9% of the primary buyout portfolio (7% at 31 December
2011). Here, the common theme is that we are backing companies that own and
develop high quality products based on technologically advanced German design
but manufactured in low cost locations.
Following strong financial performance in 2011 for SimonsVoss, a German
developer and manufacturer of digital battery powered locking and access
control systems, 2012 will be a year of investment as the company increases
its sales-force, invests in a new production site and R&D for new product
development.
Teuful is a designer and online direct retailer of loudspeaker systems in
Germany. The business is currently only seeing modest growth as investment in
the business continues to support international expansion.
During the period we completed a new buyout investment in the Industrials
sector, with the acquisition of Qundis in Germany. Qundis is a leading
provider of sub-metering devices and services. This investment represents 3.3%
of the portfolio value.
Finally, our legacy Consumer and Leisure portfolio represented 4% of the
primary buyout portfolio (4% at 31 December 2011). Businesses exposed to the
consumer, such as Americana and Schleich, continue to experience a difficult
trading environment. Sporting Index, a sports spread betting firm, experienced
a profits decline in its financial year to May 2012, compared with 2011,
albeit ahead of forecast in December. During the year we have increased
operating costs to support the development of a new trading platform, the
benefit of which we anticipate in the next financial year.
Sector by value of primary buyout portfolio*
51% TMT
19% Services
17% Healthcare
9% Industrials
4% Consumer & Leisure
Sector by class**
92% Unquoted
8% Cash & other assets
*Percentages are based on fixed assets (excluding hedges) and accrued interest
and are shown by value
**Percentages are based on net assets
Renewable energy
The Trust invests in renewable energy through RPP1 and RPP2, two UK funds
managed by our dedicated team of seven specialists. The underlying portfolios
are divided into five platforms: UK Onshore Wind, Nordic Onshore Wind, Irish
Wind, Spanish Mini-Hydro and Spanish Solar.
The assets are split into onshore wind at 72% of value, mini-hydro at 13% and
solar at 15% of value. All use proven and commercially viable technologies
within the framework of current power price regimes across Europe. Each
platform's operating performance since inception continues to be in line with
our original investment case. The investment case for power generation remains
positive as Western Europe faces both a huge need to re-equip its creaking
power infrastructure and to reduce its CO2 emissions.
The Spanish government is conducting a broad regulatory review of its power
sector as part of its aim to tackle the shortfall between the power sector
costs and what consumers pay. While the content of the reform is unknown,
there are rumours that it may include levies on conventional generators and
renewable energy plants including the Trust's investments in Spain. The level
of such levies is unknown and their impact could therefore range between the
negligible and a material impairment. Draft legislation is expected to be
available later in the year.
Since the period end, HgCapital has sold its operating UK onshore wind
portfolio to Munich Re, represented by its asset management arm MEAG. The
portfolio includes the 21.25MW Tir Mostyn wind farm in North Wales, the 16MW
Bagmoor wind farm in Lincolnshire and the 65MW Scout Moor wind farm near
Manchester; they have a combined capacity of 102MW. The Trust's original
investment in these wind farms was £3.3 million. The sale proceeds and
operating cash distributions from the portfolio totalled £6.6 million,
representing a 2.0x money multiple and an IRR of 20% p.a. Following the sale
HgCapital still holds controlling interests in RidgeWind, which includes 44MW
of wind farms in construction, 34MW fully permitted and ready to start
construction and a pre-permitting pipeline in excess of 150MW.
Mercury
In the second half of 2011, the Trust made a £60 million commitment to the
Manager's new Mercury Fund, specialising in TMT investments with an Enterprise
Value of between £20 million and £80 million. This is an area where the
Manager has historically made many profitable investments and has now set up a
dedicated team of investment professionals focused on this niche.
This dedicated fund is intended to target smaller buyouts in the same thematic
TMT sub-sectors but with significant incremental resources added to the
existing HgCapital sector team. The addition of Mercury alongside the existing
TMT team further reinforces the scale and capability of HgCapital within this
sector.
To date the fund has not made any investments but has a strong pipeline of
interesting opportunities and we anticipate deploying capital over the next
six months.
Geography, Vintage Analysis
Over 90% of the portfolio by value is invested in Northern Europe. Just over
half the portfolio was invested in the last two and a half years and although
still relatively immature we are starting to see the impact of strong trading
over the period both attract the attention of potential buyers and contribute
to an increase in our valuations.
Prospects
The macro-economic environment remains weak across Western Europe and, over
the last year, we have seen a clear downturn in both key economic indicators
and market sentiment across most of the regions in which we invest. With a
cautious view of Western European economic prospects since 2009, assuming
minimal levels of GDP growth and greater volatility, we have generally taken a
more bearish stance than most financial commentators over the period. We do
believe, however, that macro-economic factors have relatively little bearing
on our investment performance over the medium and long-term because our
investment strategy is focused on using our sector expertise to identify
market niches that exhibit strong secular growth, despite a weak overall
economy, and provide consistent opportunities to invest in businesses that
benefit from these fundamental growth trends.
Our sector expertise, developed over 10-15 years, is used to identify high
quality, growth companies in market niches, typically growing at 2-3 times GDP
driven by fundamental long-term factors. The most obvious example is the
increasing penetration of internet-based transactions for businesses, a trend
identified many years ago by us and exploited in several different sectors.
Companies such as SHL, Achilles, Epyx, Lumesse and Group NBT all benefit from
this trend and have produced revenue and profit growth in excess of 10% p.a.
since 2008. We believe that such companies will be attractive to both trade
and financial buyers when the time comes to realise these investments.
Geographic spread by value*
62% UK
14% Nordic Region
10% Germany
8% Italy
5% Benelux
1% Switzerland
Vintage by value*
4% 2012
21% 2011
29% 2010
12% 2009
7% 2008
27% pre 2008
Deal type by value*
94% Buyout
6% Renewable energy
*Percentages are based on fixed assets (excluding hedges) and accrued interest
and are shown by value
INVESTMENTS
£19.7 million invested
One new buyout investment was made with the acquisition of Qundis, at a total
enterprise value of €151 million. This required investment of £76.8 million in
equity from our clients, with the Trust's share being £11.5 million.
Qundis supplies a comprehensive range of sub-metering devices, including heat
cost allocators, heat meters and water meters used to measure, collect and
transmit consumption-dependent data for heating and water usage on a unit
level.
The Trust invested £8.2 million into further investments over the period, of
which £1.9 million was used to fund the acquisition of Solar Care Group by
Voyage.
A total of £4.0 million of the Trust's funds were invested into renewable
power assets. This included a new investment in a Spanish hydroelectric plant
and further investment into our Nordic Wind platform.
INVESTMENTS MADE DURING THE PERIOD*
Company Sector Geography Activity Deal type Cost
£'000
Qundis Industrials Germany Provider of Buyout 11,527
sub-metering
devices & systems
New investments 11,527
RPP2 Fund Renewable Europe Renewable energy fund Fund 3,292
energy
Voyage Healthcare UK Care home operator Buyout 1,931
Sporting Index Consumer & UK Sports spread betting Buyout 938
Leisure firm
RPP1 Fund Renewable Europe Renewable energy fund Fund 751
energy
Casa Reha Healthcare Germany Care home operator Buyout 694
Other investments(1) 597
Further 8,203
investments
Total investment 19,730
by the Trust
* The numbers in the table relate to the Trust's share of transactions
(1) Includes secondary participation in HgCapital 6 E LP
REALISATIONS
Realised £8.1 million from current investments
During the first half of 2012, Mainio Vire, a leading Finnish care home
provider, was refinanced returning £26 million of proceeds for our clients,
the Trust's share being £3.7 million.
£15 million of our investment in Group NBT, the domain name management
business, was syndicated to a co-investor. The Trust's share of this was £2.4
million.
In addition, other proceeds of £2.0 million were received from a number of
investments, including £0.5 million of interest proceeds that the Trust
received from Epyx, resulting from strong cash generation.
REALISATIONS MADE DURING THE PERIOD*
Cumulative Current
gain/ year
(loss)(2) gain/
Cost Proceeds(1) (loss)(3)
Company Sector Exit route £'000 £'000 £'000 £'000
Mainio Vire Healthcare Refinancing 4,022 3,683 (339) (78)
Group NBT TMT Syndication 2,374 2,374 - -
to
co-investor
Epyx TMT Loan stock - 474 474 -
interest
Other 541 1,541 1,000 886
Partial 6,937 8,072 1,135 808
realisations
* The numbers in the table relate to the Trust's share of transactions
(1) Includes gross revenue received during the period
(2) Realised proceeds including gross revenue received, in excess of historic cost
(3) Realised proceeds including gross revenue received, in excess of 31 December 2011
book value and accrued interest
Realisations since 30 June 2012
Since the period end we have realised three investments resulting in a NAV per
share uplift of 28.6p over the June 2012 valuation.
SHL, the global leader in talent management, was sold to a US trade buyer, The
Corporate Executive Board Company, for $660 million. The sale represents an
investment multiple of 3.1x original cost and a gross IRR of 26% p.a. over the
investment period. The proceeds from the sale for the Trust were £26.8
million, which was fully reflected in the net asset value of the Trust at 30
June 2012.
RPP1's UK Onshore Wind portfolio was sold to the asset management arm of
Munich Re, MEAG, at an investment multiple of 2.0x and a gross IRR of 20% p.a.
The proceeds from the sale returned £5.9 million to the Trust.
In August, we announced the sale of Mercury Pharma to Cinven, a private equity
investor, for £465 million. The initial proceeds from the sale realised £35.4
million in cash. This represents a total return of 4.1x original cost
(potentially rising to 4.3x) and a gross IRR of 67% p.a. over the investment
period.
Investment portfolio
THE TOP 20 PRIMARY BUYOUT INVESTMENTS ACCOUNT FOR 86% OF THE PORTFOLIO BY VALUE
Investments (in Sector Location Year of Residual Total Portfolio Cum.
order of value) investment cost valuation(1) value Value
Primary buyout £'000 £'000 % %
investments
1 Visma Norway Holdco TMT Nordic 2006 701 28,055 8.1% 8.1%
Region
2 SHL Group Holdings 1 Services UK 2006 7,991 26,810 7.8% 15.9%
Ltd
3 Mercury Pharma Group Healthcare UK 2009 8,545 26,204 7.6% 23.5%
Limited(2)
4 IAS Guernsey Limited TMT UK 2011 25,598 25,598 7.4% 30.9%
5 TeamSystem Holdco SARL TMT Italy 2010 24,432 25,312 7.3% 38.2%
6 Lumesse Holdings SARL TMT UK 2010 15,776 18,029 5.2% 43.4%
7 Achilles Group TMT UK 2008 5,226 17,416 5.1% 48.5%
Holdings Limited
8 ATC Holdco SARL Services Benelux 2011 9,913 15,488 4.5% 53.0%
9 Group NBT Equityco TMT UK 2011 14,249 14,249 4.1% 57.1%
Limited
10 JLA Equityco Limited Services UK 2010 12,227 12,848 3.7% 60.8%
11 Epyx Investments TMT UK 2009 6,388 12,368 3.6% 64.4%
Limited
12 Manx Telecom Ltd TMT UK 2010 11,033 11,917 3.5% 67.9%
13 Qundis Luxembourg SARL Industrials Germany 2012 11,527 11,469 3.3% 71.2%
14 Voyage Holdings Healthcare UK 2006 15,067 11,413 3.3% 74.5%
Limited
15 Frösunda Luxco SARL Healthcare Nordic 2010 14,296 7,824 2.3% 76.8%
Region
16 SimonsVoss Luxco SARL Industrials Germany 2010 7,901 7,171 2.1% 78.9%
17 Schleich Luxembourg SA Consumer & Germany 2006 4,650 6,529 1.9% 80.8%
Leisure
18 Sporting Index Group Consumer & UK 2005 7,440 5,873 1.7% 82.5%
Holdings Limited Leisure
19 Teufel Holdco SARL Industrials Germany 2010 9,420 5,506 1.6% 84.1%
20 CSH Limited TMT UK 2011 5,058 5,058 1.5% 85.6%
21 Mainio Vire Sarl Healthcare Nordic 2011 8,309 4,566 1.3% 86.9%
Region
22 Atlas Energy Group Services UK 2007 9,597 3,206 1.0% 87.9%
Limited
23 Mondo Minerals Co-op Industrials Nordic 2007 - 1,785 0.6% 88.5%
Region
24 KVT Coinvest Sarl Industrials Switzerland 2008 5,828 1,766 0.5% 89.0%
25 Casa Reha SARL Healthcare Germany 2008 8,990 1,507 0.4% 89.4%
26 Americana Consumer & UK 2007 4,625 1,453 0.4% 89.8%
International Holdings Leisure
Ltd
27 Weston Presidio Fund North 1998 1,208 770 0.2% 90.0%
Capital III, LP America
28 Tiger Capital Ltd TMT UK 2008 632 395 0.1% 90.1%
29 ACT Venture Capital Fund Ireland 1994 27 24 - 90.1%
Ltd
30 Elite Holding SA TMT Benelux 2005 - - - 90.1%
31 W.E.T Holding Industrials Germany 2003 7,774 - - 90.1%
Luxembourg SA
32 BMFGH II BV Services Benelux 2007 - - - 90.1%
Total primary buyout 264,428 310,609 90.1%
investments(3)
Secondary buyout
investments
1 HgCapital 6 E LP Fund UK 2011 10,706 10,555 3.1% 93.2%
Total buyout 275,134 321,164 93.2%
investments
Renewable energy
investments
1 RPP1 Fund Renewable Europe 2006 15,726 15,239 4.4% 97.6%
energy
2 RPP2 Fund Renewable Europe 2010 9,692 8,133 2.4% 100.0%
energy
Total renewable energy 25,418 23,372 6.8%
investments
Total all investments 300,552 344,536 100.0%
(35)
(1) Including investment valuation of £301,554,000 and accrued interest of
£42,982,000.
(2) Previously known as Goldshield Equityco SARL.
(3) Buyout investments are held through the Trust's investment in HGT LP and HGT6 LP.
TOP 10 PRIMARY BUYOUT INVESTMENTS
representing 61% of the total portfolio
Primary buyout investments are held through limited partnerships of which
HgCapital Trust plc (the `Trust') is the sole limited partner. The Trust
invests alongside other clients of HgCapital. Typically, the Trust's holding
forms part of a much larger majority interest held by HgCapital clients in
buyout investments in companies with an enterprise value (`EV') of between £20
million and £500 million. The Manager's review generally refers to each
transaction in its entirety, apart from the tables detailing the Trust's
participation or where it specifically says otherwise.
1 Visma
Website: www.visma.com
Original enterprise value: NOK4.3 billion
HgCapital clients' total equity: 16.3%
Business description
VISMA is the number one provider of mission-critical business software and
out-sourcing services to small and medium-sized enterprises in the Nordic
region.
The company provides accounting, resource planning and payroll software,
outsourced book-keeping, payroll services and transaction process outsourcing.
Why did we invest?
Visma is an early example of HgCapital's focus on business critical `software
as a service' firms operating within a fast growing marketplace.
The company enjoys high levels of predictable recurring revenue resulting from
a subscription payment model.
Room for improvement was identified in revenue growth opportunities and profit
margins that were below those of most of its competitors. This was due to
significant R&D investment in the business and a delay in the benefits
expected from a number of recent acquisitions.
How do we intend to create value?
In September 2010, a 64% stake in the business was sold to KKR. This valued
the business at £1.2 billion, of which our clients' stake was worth £380.0
million (an investment multiple of 3.7x).
What has been achieved?
During the course of the investment, the company has made several bolt-on
acquisitions including Accountview, Sirius IT and Mamut ASA. These deals
bolstered organic growth from innovation in new services and products, while
margins were improved through rethinking Visma's internal processes.
How is it performing?
The last six months have seen continued improvement with strong revenue and
EBITDA growth compared to the prior year.
How will we crystallise value?
The business has a scale and growth profile which will make it an attractive
IPO candidate, as well as a target for trade buyers.
Trust's investment - Visma
Sector Location Date of Residual cost Unrealised Fair value
investment £'000 value classification
£'000
TMT Nordic Region May 2006 701 28,055 Earnings
2 SHL
Website: www.shl.com
Original enterprise value: £102 million
HgCapital clients' total equity: 50.5%
Business description
SHL is the global market leader in objective psychometric assessment and has a
world-wide presence.
The business consists of the development and sale of 300 different types of
psychometric tools to corporate clients and the provision of psychologists for
the administration and interpretation of tests.
Why did we invest?
SHL's enviable share of a growth market with a blue chip customer base
provided an opportunity to invest aggressively to increase SHL's share of
customer spend and access high growth geographies through focusing on new
technology and products.
How did we intend to create value?
The plan was to invest in new sales resources, to focus the business on higher
margin web sales and to invest in new technology to increase product
performance.
What has been achieved?
Following a tough year in 2009 when revenues fell and costs were cut rapidly,
productivity increased and the business has rebounded strongly, with profits
and revenues increasing significantly. A merger with US-based PreVisor was
completed in January 2011.
The deal was executed on an all-equity basis, with a rollover of all existing
management ownership into the combined business, and no additional funding
requirement from clients. HgCapital retained a 50.5% stake of the enlarged
group, with Veronis Suhler Stevenson, the private equity investor in PreVisor,
holding a minority position.
The merged company will be able to provide a broad range of assessment
solutions across both blue and white-collar roles to support both recruitment
and development decisions. Its offering will be available in more languages
and countries than any other talent management provider in the world.
How is it performing?
The six months to June 2012 were strong with both sales and EBITDA ahead of
last year.
Exit
Shortly after the period end we sold SHL to a US trade buyer, The Corporate
Executive Board Company, for $660 million. The sale represents an investment
multiple of 3.1x original cost and a gross IRR of 26% p.a. over the investment
period.
Trust's investment - SHL
Sector Location Date of Residual cost Unrealised Fair value
investment £'000 value classification
£'000
Services UK Oct 2006 7,991 26,810 Sale proceeds
3 Mercury Pharma (previously known as Goldshield)
Website: www.mercurypharma.com
Original enterprise value: £132 million
HgCapital clients' total equity: 53.2%
Business description
Mercury Pharma is a profitable niche pharmaceutical company based in the UK.
It distributes niche branded original and non-branded generic medicines.
Although the product portfolio is diversified well, the company has particular
strength in pain relief products and hospital supply.
It is primarily focused on serving the UK, where demand for its products
benefits from attempts to reduce prescription costs. The principal growth
drivers are the life-cycle management of its existing drugs as well as the
targeted development, in-licensing, or acquisition of further products.
Why did we invest?
The business operates in a niche of the pharmaceuticals market and can act as
a platform for acquisition-based growth. It benefits from having a lean
operating model which delivers attractive margins and strong cash conversion.
We believe that surplus cash can be used to acquire new products and to
finance licensing deals that will extend the product portfolio and deliver
continued growth.
How did we intend to create value?
We have created value in three distinct ways. First, we spun off all non-core
activities and refocused the business on its pharmaceutical core. Second, we
invested into quality, improving both supply chain and regulatory performance.
Finally, we increased business development spending, thereby accelerating
organic growth.
What has been achieved?
The rebranding reflects the completion of a streamlining process following the
disposal of the Consumer Health division and other non-core assets. A new
management team has been recruited including the Chairman, CEO and Heads of
Operations and Business Development. The new executives have driven
improvements in their respective areas, leading to a solid financial
performance.
How is it performing?
The company has performed well financially since our acquisition. We have, in
line with our investment case, disposed all non-core activities and
rejuvenated the company's pipeline of new products. As a result, the business
has shown strong year-on-year growth.
Exit
Since the period end we have agreed the sale of Mercury Pharma to Cinven, a
private equity investor, for £465 million. The initial proceeds from the sale
represent an investment multiple of more than 4.1x (which could increase to
4.3x once all further potential proceeds have been received) and a gross IRR
of 67% p.a. over the investment period. This sale was made at an uplift of
£10.2 million to the June valuation of the Trust's investment.
Trust's investment - Mercury Pharma
Sector Location Date of Residual cost Unrealised Fair value
investment £'000 value classification
£'000
Healthcare UK Dec 2009 8,545 26,204 Earnings
4 Iris Accountancy Solutions (IAS)
Website: www.iris.co.uk
Original enterprise value: £425 million
HgCapital clients' total equity: 68.8%
Business description
Iris Accountancy Solutions (IAS) is the leading provider of core application
software to the UK accountancy market and a leading provider of payroll
software to SMEs and niche vertical markets. Headquartered in Berkshire, the
company has 370 employees and 14,000 customers.
Why did we invest?
HgCapital has been an investor in IAS since 2004, retaining a minority stake
following its sale in 2007. IAS is one of the earliest examples of our focus
on business critical software firms operating in attractive, predictable
end-markets.
IAS is a highly predictable business with c.90% of revenue coming from
recurring subscription contracts. The company has grown consistently through
the recession with organic growth in excess of 7% even in its poorest year.
The investment decision was based on our belief in continued organic growth
potential and consolidation opportunities through acquisition, coupled with
the improvement in performance demonstrated by the business following the
recruitment of the present CEO into what was then a divisional management
position.
How do we intend to create value?
The company is achieving sound levels of organic revenue and profit growth
through a combination of market share gains, price optimisation, and the
ongoing development of new products and services to sell into the existing
customer base (IAS is very strong on this last point vs. other such companies
in the market). Furthermore, the UK accountancy and SME software markets
remain fragmented, offering additional acquisition opportunities to IAS.
What has been achieved?
Significant investment has been made into management with a new Group CFO, a
new MD of the SME software division and a new HR director. The CEO has also
made good early progress in achieving revenue synergies and applying best
practice between the Accounting Software and SME payroll divisions.
How is it performing?
Current organic revenue growth is strong due to the rapid uptake by existing
customers of newly launched products. Over the last six months revenue has
grown organically at 9%.
How will we crystallise value?
IAS would be an attractive acquisition target to private equity players due to
its high organic growth, margins, cash conversion and recurring revenue
levels. It would also be a strong strategic fit with a number of tax and
financial information providers and other larger software companies.
Trust's investment - Iris Accountancy Solutions
Sector Location Date of Residual cost Unrealised Fair value
investment £'000 value classification
£'000
TMT UK Dec 2011 25,598 25,598 Price of
recent
investment
5 TeamSystem
Website: www.teamsystem.com
Original enterprise value: €562 million
HgCapital clients' total equity: 50.0%
Business description
TeamSystem is a leading market provider of business-critical, daily-use SME
software products in Italy. Headquartered in Pesaro, the company has a diverse
base of over 90,000 customers. It has 27 offices in Italy and employs
approximately 900 people.
Why did we invest?
TeamSystem is HgCapital's fifth platform investment into business-critical
back office software, following Iris (2004), Addison (2005), Visma (2006) and
CSG (2007). The company has a track record of solid growth throughout the
economic cycle and delivered compound organic revenue growth of 6% p.a.
between 2007 and 2009, trading resiliently through that downturn. Its stable
nature (with more than 50% of revenues by way of annual subscriptions), strong
cash generation and potential for growth in both the business and its market,
all supported our decision.
How do we intend to create value?
Alongside organic growth, management has increased its cross-sell of products
to TeamSystem's existing client base through the use of add-on modules such as
reporting, analytics and payroll. The potential to complete a number of add-on
acquisitions of complementary businesses in Italy has also been identified;
the company has completed four such bolt-ons under our ownership.
What has been achieved?
Our normal post-acquisition review has identified several improvement projects
that have been put into action, including improved reporting and pricing,
investment into the M&A process and finding new ways to address the micro-SME
customer base in Italy. We are acting directly on these - for example, in
December 2011 TeamSystem acquired a controlling stake in Daneasoft, a provider
of accounting software to the Italian micro-SME market.
How is it performing?
Trading has been sound with good growth in revenue and profits. Despite a
poorly performing Italian economy, TeamSystem's revenue and EBITDA growth well
in excess of GDP (and to achieve positive organic growth even when GDP growth
is negative) is an attractive characteristic of this and our other accounting
software businesses in other countries.
How will we crystallise value?
We see a diverse range of exit options for TeamSystem, with interest from
trade and financial buyers expected and an IPO on the Italian stock market a
possibility.
Trust's investment - TeamSystem
Sector Location Date of Residual cost Unrealised Fair value
investment £'000 value classification
£'000
TMT Italy Sep 2010 24,432 25,312 Earnings
6 Lumesse
Website: www.lumesse.com
Original enterprise value: €110 million
HgCapital clients' total equity: 81.8%
Business description
Lumesse is a leading provider of strategic HR software (recruiting and talent
management) to medium and large enterprises in Europe, operating in 16
countries with c. 600 full-time employees.
The business operates a subscription-based model (more than 60% of total
revenue) with a recurring consulting element. Customer retention rates are
high at around 94%.
Why did we invest?
As a SaaS (Software as a Service) provider, Lumesse lies within one of our
core sub-sector focus areas. SaaS companies experience high levels of
recurring revenue from long-term customers, which leads to stability and high
margins. In addition, the company has achieved strong organic growth.
How do we intend to create value?
Lumesse's management intends to drive subscription revenue growth by
capitalising on their cutting-edge technology, improving cross- and up-selling
into the existing customer base.
There is also an increased focus on efficiency and scale effects with a view
to improving margins and strengthening the company's international presence
both organically and through bolt-on acquisitions.
What has been achieved?
Two bolt-on acquisitions, Mr. Ted and Edvantage, have been made and Mr.Ted's
global Talentlink product and Edvantage's Learning Management suite have been
added to the Lumesse range of services. Investment in the sales force has
helped to drive organic growth. Lumesse's senior management team has been
strengthened with significant new hires, while internal process projects on
pricing, back-office management and sales practices have been initiated.
How is it performing?
Recurring software revenue is ahead of prior year and ahead of plan with
strong organic growth. Consulting services are behind plan, as a result of a
shift in product mix towards Talentlink, which requires less upfront
consulting, and general economic circumstance, with customers holding back on
capital expenditures. As a result, EBITDA is behind plan but still showing
good growth versus last year.
How will we crystallise value?
Multiple options are available as there is high demand for SaaS companies, in
particular in Lumesse's market. Lumesse has received strong interest from
trade buyers but we may also contemplate an IPO or a sale to another private
equity buyer.
Trust's investment - Lumesse
Sector Location Date of Residual cost Unrealised Fair value
investment £'000 value classification
£'000
TMT UK May 2010 15,776 18,029 Earnings
7 Achilles
Website: www.achilles.com
Original enterprise value: £75 million
HgCapital clients' total equity: 63.2%
Business description
Achilles operates an online platform whereby buyers require their suppliers to
subscribe and to provide information to the Achilles online database;
suppliers join the platform if they wish to supply to the buyer group and both
buyers and suppliers pay annual subscription fees.
Achilles currently operates more than 30 schemes across 22 countries.
Why did we invest?
Achilles is a prime example of HgCapital's subscription-based thematic
investment strategy. It is a market leader in the regulatory compliance
industry, with significant recurring revenue streams.
How do we intend to create value?
With high levels of contracted revenue, Achilles' position as global market
leader with a scalable business model reveals considerable potential in
revenue and margin growth.
What has been achieved?
Achilles' senior management team has been strengthened with significant new
hires, while internal process projects on pricing, back-office management and
sales practices are beginning to bear fruit.
The business is now deploying new schemes on a new standard IT system and has
started migrating some existing schemes to the same platform. A detailed
review and development of IT was led by HgCapital-appointed experts.
Achilles is in the process of rolling out its services to the network of a
major new global customer.
How is it performing?
Performance has been significantly up on the prior year with good growth in
both sales and EBITDA.
How will we crystallise value?
There has been strong interest from both the strategic and private equity
communities and Achilles' protected revenue base is likely to maintain this
interest throughout the economic cycle. A trade sale or IPO are also
attractive outcomes with an IPO likely to offer the best long-term value.
Trust's investment - Achilles
Sector Location Date of Residual cost Unrealised Fair value
investment £'000 value classification
£'000
TMT UK Jul 2008 5,226 17,416 Earnings
8 ATC Group
Website: www.atcgroup.com
Original enterprise value: €187 million
HgCapital clients' total equity: 61.7%
Business description
ATC provides fiduciary, management and administration services to
corporations, financial institutions and fund managers through its presence
across the globe.
The company sets up and maintains corporate structures that allow the
efficient intra-group movement of cash and/or balance sheet management, e.g.
divisional holding companies or acquisition bid vehicles.
Corporate structures typically last for seven to ten years and need to comply
with legal, accounting and tax regulations in multiple jurisdictions, a
complex task for clients to manage themselves. ATC uses functional expertise
and economies of scale to provide these services for a fraction of the cost of
in-house provision.
Why did we invest?
The fiduciary services market is a structurally high growth market, achieving
3x GDP growth rates over multiple decades. The multi-year nature of corporate
structures leads to predictable and recurring revenues, low customer
concentration and high margins.
The company achieves the highest revenue per structure in the sector, a
reflection of the sophisticated services it provides to the highest value and
most resilient segment of the market place. Finally, ATC has very low capital
expenditure and working capital requirements, leading to high cash conversion.
How do we intend to create value?
HgCapital will support investment into a professional sales force to drive
revenue growth and assist in selective acquisitions, with a clear focus on
high margin service providers operating in onshore jurisdictions.
Investment in sales efficiency will help to manage the sales team and allow
clearer analysis of the sources of growth.
What has been achieved?
HgCapital helped ATC's management to launch a number of programmes including
leadership assessment and development and sales effectiveness, as well as
initiating a sales force reorganisation. A strong HR function has been
developed alongside the recruitment of a new Chairman. The team was also
assisted in the evaluation of a number of acquisition opportunities.
How is it performing?
In the six months to June 2012, ATC delivered strong revenue and EBITDA
growth. Growing business in the core jurisdictions of the Netherlands and
Luxembourg were the primary drivers of the strong performance.
How will we crystallise value?
There are a number of options for exit available, including a sale to a
strategic buyer or a secondary buyout.
Trust's investment - ATC Group
Sector Location Date of Residual cost Unrealised Fair value
investment £'000 value classification
£'000
Services Benelux Mar 2011 9,913 15,488 Earnings
9 Group NBT
Website: www.groupnbt.com
Original enterprise value: £141 million
HgCapital clients' total equity: 75.7%
Business description
Group NBT is a UK based European leader in online intellectual property asset
management. With the online channel increasingly important for commercial and
marketing activities, Group NBT offers a single point of contact for global
domain name management and the protection of brands across all online
environments.
The company offers an expertise, infrastructure and service which is hard for
corporates to match and enjoys long-term relationships with c.2,500 mid- to
large-sized firms.
Why did we invest?
As a sector leader in Europe in an area where increasing corporate internet
use is driving growth, Group NBT is well positioned. The company has a record
of strong performance through the cycle, growing through the downturn. Group
NBT has also made a number of acquisitions which have built on its product
range and geographic reach. The business also receives recurring revenue from
a diverse customer base.
How do we intend to create value?
HgCapital will continue to support the growth plan with further investment in
the sales force, maximisation of value from existing customers and further
geographic expansion. We see opportunity to improve margins as the business
grows through synergies in back office systems and from recent acquisitions.
In addition, we will look to make further strategic bolt-on acquisitions.
What has been achieved?
Group NBT's new CEO has had a beneficial impact on the business and, in July
2012, a new CFO, COO and Sales Director joined the company, which we
anticipate will further professionalise operations. On 1 July 2012, the
company completed the sale of its non-core Managed Hosting division for £25
million to a trade buyer. The company has retained the cash from this sale in
order to make further acquisitions (most likely smaller bolt-ons similar to
Cedel AB which the company acquired in March 2012).
How is it performing?
Group NBT has traded well to the end of its financial year (30 June 2012).
Full year organic revenue growth was c.9%. Revenue, EBITDA and cashflow for
the year exceeded expectations.
How will we crystallise value?
We believe that Group NBT will be attractive to a number of strategic buyers
who are looking to broaden their product range into a core, growing area of
the legal, IP and marketing support space. The significant market opportunity,
robust business model and growth record will drive interest from investors
looking for a cash generative asset in a fast growing market. The business was
highly regarded in its time on the public markets and we expect an IPO to be
another potential exit option.
Trust's investment - Group NBT
Sector Location Date of Residual cost Unrealised Fair value
investment £'000 value classification
£'000
TMT UK Nov 2011 14,249 14,249 Price of
recent
investment
10 JLA
Website: www.jla.com
Original enterprise value: £150 million
HgCapital clients' total equity: 86.4%
Business description
JLA is the number one service provider to the on-premises laundry sector in
the UK, providing distribution, rental and servicing of commercial laundry
machines to more than 18,000 UK SMEs.
The company is also the leading provider of coin-operated, commercial machines
into accommodation units (e.g. universities, worker accommodation units etc.)
which it services via its Circuit brand.
Why did we invest?
JLA is a market leader with strong operating performance, including sustained
organic growth through the period 2007-2009.
The customer base is highly fragmented and considers laundry as a mission
critical part of their day-to-day business. With a high proportion of
customers in long-term contracts (representing over 70% of revenues and 85%+
of profits), there are attractive recurring revenues.
How do we intend to create value?
HgCapital is working alongside management to increase the benefit of selling
new products and services through JLA's existing sales force and service
network.
In addition, there are plans to drive add-on acquisitions, both in the laundry
space and in adjacent areas.
What has been achieved?
A number of projects have been initiated covering strategic planning, customer
retention and pricing. In addition, a new CEO and CFO have been recruited and
four smaller acquisitions have been completed, funded out of free cash flow
with a pipeline of further acquisitions put into place.
How is it performing?
JLA grew its revenues by 9% in the first half of 2012. Following a year of
heavy investment into infrastructure in 2011, EBITDA has risen 11% over the
first six months of 2012. This growth has been driven by a new management team
and innovative sales initiatives.
How will we crystallise value?
The most likely exit route for JLA is either a secondary sale or a trade sale.
Ahead of exit, HgCapital will focus on repositioning JLA as a platform for
selling hard facility management services into SMEs, which could potentially
lead to a re-rating of the business.
Trust's investment - JLA
Sector Location Date of Residual cost Unrealised Fair value
investment £'000 value classification
£'000
Services UK Mar 2010 12,227 12,848 Earnings
INVESTMENTS IN RENEWABLE ENERGY
Business description
HgCapital's Renewable Energy sector team uses private equity skills to
identify and acquire renewable energy projects, usually based on wind or solar
energy, in Western Europe. These projects run across two funds and are grouped
into platforms with the current portfolio comprising:
- UK Onshore Wind: one of the ten largest independently-owned onshore wind
portfolios in the UK with 113MW of capacity in operation and 44MW in
construction;
- Nordic Onshore Wind: the largest owner of onshore wind farms in the Nordic
region with total capacity of 181MW in three projects, developed and built by
Renewable Energy Systems Limited, one of the world's most experienced
developers of wind farms;
- Spanish Solar: the fourth largest operator of solar PV in Europe with
capacity of 61MW in seven projects in Spain;
- Spanish Hydro: 34 projects of 120MW operating with 16MW to be built in the
next 12 months; and
- Irish Onshore Wind: Establishment of projects in various stages of
pre-construction.
As at 30 June 2012, electricity equivalent to the power consumption of more
than 240,000 homes is generated from the operational energy plants in the
portfolio.
Why do we invest?
Investment in renewable energy offers good, risk-adjusted returns, delivering
inflation-protected and non-GDP linked revenue streams from high quality
assets.
It is the fastest growing part of the European electric power sector, and is
expected to account for the majority of new European energy asset investment
over the next ten years. This growing demand is driven by renewable energy's
increasing cost competitiveness, legally binding carbon reduction targets set
by the EU, the need to replace ageing generation capacity, and to increase the
security of energy supplies in Europe.
The sector shares the attractive characteristics, including downside
protection, of core infrastructure projects with the potential for
significantly higher returns on equity.
How do we intend to create value?
Investment returns are anticipated through a combination of yield during
operation and capital gain at refinancing or exit, providing a return profile
that should complement returns from its core investments in leveraged buyouts.
By bringing individual investments together into platforms, value can be
enhanced through economies of scale, shared expertise and aggregated
generation capacity.
How will we crystallise value?
HgCapital is developing groups of projects based on the platforms shown below.
These platforms can then be refinanced efficiently or sold as portfolios of
closely related projects to industry buyers or financial investors.
Exit
In August 2012, HgCapital announced the sale of RPP1's UK Onshore Wind
operating assets to the asset management arm of Munich Re, MEAG, at an
investment multiple of 2.0x and a gross IRR of 20%. HgCapital has retained the
UK Wind development assets.
Principal investments by platform Total Portfolio
valuation value
£'000 %
UK Wind 8,962 2.6
Spanish Solar 3,444 1.0
Nordic Wind 2,334 0.7
Other 499 0.1
RPP1 Fund 15,239 4.4
Nordic Wind 3,767 1.1
Spanish Mini-Hydro 2,992 0.9
Irish Wind 1,155 0.3
Liquid assets 219 0.1
RPP2 Fund 8,133 2.4
Total renewable energy investments 23,372 6.8
DIVERSIFICATION BY VALUE
Geography
40% UK
28% Spain
27% Nordic
5% Ireland
Resource
72% Onshore wind
15% Solar
13% Hydro
FINANCIAL STATEMENTS
INCOME STATEMENT
for the six months ended 30 June 2012
Revenue return Capital return Total return
Note
Six Year Six Year Six Year
months ended months ended months ended
ended ended ended
30.6.12 30.6.11 31.12.11 30.6.12 30.6.11 31.12.11 30.6.12 30.6.11 31.12.11
£'000 £'000 £'000 £'000 £'000 £'000 £'000 £'000 £'000
(unaudited) (unaudited) (audited) (unaudited) (unaudited) (audited) (unaudited) (unaudited) (audited)
Gains/(losses) - - - 21,344 18,004 (6,649) 21,344 18,004 (6,649)
on
investments and
government
securities
(Losses)/gains 7(b) - - - (58) 1,690 8,017 (58) 1,690 8,017
on loans
recoverable
from priority
profit
share due to
General
Partners
Net income 6 9,303 3,962 1,952 - - - 9,303 3,962 1,952
Other expenses 8 (1,307) (218) (2,597) - - - (1,307) (218) (2,597)
Net return on 7,996 3,744 (645) 21,286 19,694 1,368 29,282 23,438 723
ordinary
activities
before taxation
Taxation on 10 (335) (314) - - - - (335) (314) -
ordinary
activities
Net return on 7,661 3,430 (645) 21,286 19,694 1,368 28,947 23,124 723
ordinary
activities
after taxation
attributable to
reserves
Return per 11(a) 24.07p 10.99p (2.05p) 66.89p 63.08p 4.34p 90.96p 74.07p 2.29p
Ordinary share
The total return column of this statement represents the Trust's income
statement. The supplementary revenue and capital return columns are both
prepared under guidance published by the Association of Investment Companies
("AIC"). All recognised gains and losses are disclosed in the revenue and
capital columns of the income statement and as a consequence no statement of
total recognised gains and losses has been presented.
All revenue and capital items in the above statement derive from continuing
operations.
No operations were acquired or discontinued during the period.
BALANCE SHEET
as at 30 June 2012
Note 30.6.12 30.6.11 31.12.11
£'000 £'000 £'000
(unaudited) (unaudited) (audited)
Fixed assets
Investments held at
fair value
Unquoted at Directors' 301,554 249,905 265,421
valuation
Total fixed assets 301,554 249,905 265,421
Current assets - amounts
receivable after one year
Accrued income on fixed assets 42,982 28,026 30,862
Current assets - amounts
receivable within one year
Debtors 539 245 618
Government securities 26,999 91,938 48,497
Cash 4,364 2,143 4,476
Total current assets 74,884 122,352 84,453
Creditors - amounts falling (3,801) (3,239) (3,042)
due within one year
Net current assets 71,083 119,113 81,411
Net assets 372,637 369,018 346,832
Capital and reserves
Called up share capital 8,012 8,005 8,011
Share premium account 68,135 67,887 68,096
Capital redemption reserve 1,248 1,248 1,248
Capital reserve - realised 280,792 280,935 282,934
Capital reserve - unrealised (46) (3,149) (23,474)
Revenue reserve 14,496 14,092 10,017
Total equity shareholders' 372,637 369,018 346,832
funds
Basic net asset value per 11(b) 1,170.8p 1,160.4p 1,089.9p
Ordinary share
Diluted net asset value per 11(b) 1,138.3p 1,129.3p 1,069.3p
Ordinary share
Ordinary shares in issue at 11(b) 31,826,507 31,799,725 31,822,330
30 June / 31 December
CASH FLOW STATEMENT
for the six months ended 30 June 2012
Note Six months Six months Year ended
ended ended 31.12.11
30.6.12 30.6.11 £'000
£'000 £'000 (audited)
(unaudited) (unaudited)
Net cash (outflow)/inflow 9 (5,267) 3,240 3,759
from operating activities
Taxation received 7 1,581 1,590
Capital expenditure and
financial investment
Purchase of fixed asset (19,730) (29,435) (87,101)
investments
Proceeds from the sale of fixed 7,526 32,165 49,623
asset investments
Net cash (outflow)/inflow from (12,204) 2,730 (37,478)
capital expenditure and
financial investment
Financing activities
Proceeds from issue of 40 6,610 6,825
share capital
Equity dividends paid (3,182) (8,709) (8,709)
Net cash outflow from (3,142) (2,099) (1,884)
financing activities
Net cash (outflow)/inflow (20,606) 5,452 (34,013)
before management of
liquid resources
Management of liquid
resources
Purchase of government - (33,737) (117,127)
securities
Sale/redemption of 20,494 26,955 152,143
government securities
Net cash inflow/(outflow) 20,494 (6,782) 35,016
from management of
liquid resources
(Decrease)/increase in (112) (1,330) 1,003
cash and cash equivalents
in the period
Cash and cash equivalents 4,476 3,473 3,473
at 1 January
Cash and cash equivalents 4,364 2,143 4,476
at 30 June / 31 December
RECONCILIATION OF MOVEMENTS IN SHAREHOLDERS' FUNDS
for the six months ended 30 June 2012
Share Capital
Note Share premium redemption Capital Revenue
capital account reserve reserves reserve Total
£'000 £'000 £'000 £'000 £'000 £'000
At 31 December 2011 8,011 68,096 1,248 259,460 10,017 346,832
Issue of Ordinary 5 1 39 - - - 40
shares
Conversion of 5 - - - - - -
Subscription shares
Net return from - - - 21,286 7,661 28,947
ordinary activities
Dividends paid 4 - - - - (3,182) (3,182)
At 30 June 2012 8,012 68,135 1,248 280,746 14,496 372,637
At 31 December 2010 7,838 61,444 1,248 258,092 19,371 347,993
Issue of Ordinary shares 5 180 6,652 - - - 6,832
Conversion of 5 (7) - - - - (7)
Subscription shares
Net return from - - - 1,368 (645) 723
ordinary activities
Dividends paid 4 - - - - (8,709) (8,709)
At 31 December 2011 8,011 68,096 1,248 259,460 10,017 346,832
NOTES TO THE FINANCIAL STATEMENTS
1. Principal activity
The principal activity of the Trust is that of an investment trust company.
The Trust is an investment company as defined by Section 833 of the Companies
Act 2006 and an investment trust within the meaning of Sections 1158 and 1159
of the Corporation Tax Act 2010 (`CTA 2010').
2. Basis of preparation
The accounts have been prepared under the historical cost convention, except
for the revaluation of financial instruments at fair value as permitted by the
Companies Act 2006, and in accordance with applicable UK law and UK Accounting
Standards (`UK GAAP') and with the Statement of Recommended Practice
`Financial Statements of Investment Trust Companies' (`SORP'), dated January
2009. All of the Trust's operations are of a continuing nature.
The Trust has considerable financial resources and, as a consequence, the
Directors believe that the Trust is well placed to manage its business risks
successfully despite the current uncertain economic outlook. After making
enquiries, the Directors have a reasonable expectation that the Trust will
have adequate resources to continue in operational existence for the
foreseeable future.
Accordingly, they continue to adopt the going concern basis in preparing the
interim report and accounts.
The same accounting policies, presentation and methods of computation are
followed in these financial statements as applied in the Trust's previous
annual audited financial statements.
3. Organisational structure, manager arrangements and accounting policies
Partnerships
The Trust entered into three separate partnership agreements with general and
founder partners in May 2003 (subsequently revised in January 2009), January
2009 and July 2011, at which point investment holding limited partnerships
were established to carry on the business of an investor, with the Trust being
the sole limited partner in these entities.
The purpose of these partnerships, HGT LP, HGT 6 LP and HgCapital Mercury D LP
(together the `primary buyout funds') is to hold all the Trust's investments
in primary buyouts and other investments, other than liquid funds. Under the
partnership agreements, the Trust made capital commitments into the primary
buyout funds with the result that the Trust now holds direct investments in
the primary buyout funds and an indirect investment in the fixed asset
investments that are held by these funds, as it is the sole limited partner.
The fixed asset investments on the balance sheet and the investment portfolio
above comprise the underlying investments held by these primary buyout funds.
In July 2011, the Trust made a direct secondary investment into HgCapital 6 E
LP (`Hg6 E LP'), one of the partnerships that comprise the Hg6 funds, in which
the Trust is now a limited partner alongside other limited partners. This is a
direct investment in the HgCapital 6 E LP fund, as shown on the balance sheet
and the investment portfolio above.
The Trust also entered into partnership agreements with the purpose of
investing in renewable energy projects by making capital commitments alongside
other limited partners in Hg Renewable Power Partners LP (`Hg RPP LP') and
HgCapital Renewable Power Partners 2 C LP (`Hg RPP2 LP') (together the
`renewable funds'). These are direct investments in the renewable funds, as
shown on the balance sheet and the investment portfolio above.
Priority profit share and carried interest per the primary buyout limited
partnership agreements
Under the terms of the primary buyout fund limited partnership agreements
(`LPAs'), the general partner is entitled to appropriate, as a first charge on
the net income of the funds, an amount equivalent to its priority profit share
(`PPS'). The Trust is entitled to net income from the funds, after payment of
the PPS.
In years in which these funds have not yet earned sufficient net income to
satisfy the PPS, the entitlement is carried forward to the following years.
The PPS is payable quarterly in advance, even if insufficient net income has
been earned. Where the cash amount paid exceeds the net income, an interest
free loan is advanced to the general partner by these primary buyout funds,
which is funded via a loan from the Trust. Such loan is only recoverable from
the general partner by an appropriation of net income; until net income is
earned, no value is attributed to this loan.
Furthermore, under the primary buyout funds' LPAs, the founder partner is
entitled to a carried interest distribution once certain preferred returns are
met. The LPAs stipulate that the primary buyout funds' capital gains (or net
income), after payment of the carried interest, are distributed to the Trust.
Accordingly, the Trust's entitlement to net income and net capital gains are
shown in the appropriate lines of the income statement. Notes 6, 7 and 9 to
the financial statements and the cash flow statement disclose the gross income
and gross capital gains of the primary buyout funds (including the associated
cash flows) and also reflect the proportion of net income and capital gains in
the buyout funds that have been paid to the general partner as its PPS and to
the founder partner as carried interest, where applicable.
The PPS paid from net income is charged to the revenue account in the income
statement, whereas PPS paid as an interest-free loan, if any, is charged as an
unrealised depreciation to the capital return on the income statement.
4. Dividends
It is intended that dividends will be declared and paid annually in respect of
each accounting period. A dividend of 10.0p per share was paid on 15 May 2012
in respect of the year ended 31 December 2011 (year ended 31 December 2010:
dividend of 28.0p per share).
5. Issued share capital
Six months ended Six months ended Year ended
30.6.12 30.6.11 31.12.11
(unaudited) (unaudited) (audited)
No. `000 £'000 No. `000 £'000 No. `000 £'000
Ordinary shares of
25p each
Allotted, called up
and fully paid
At 1 January 31,822 7,956 31,104 7,776 31,104 7,776
Issued following 5 1 696 174 718 180
exercise of Subscription
rights
At 30 June / 31 31,827 7,957 31,800 7,950 31,822 7,956
December
Subscription shares
of 1p each
Allotted, called-up
and fully paid
At 1 January 5,503 55 6,221 62 6,221 62
Conversion into (5) - (696) (7) (718) (7)
Ordinary shares
At 30 June / 31 5,498 55 5,525 55 5,503 55
December
Total share 37,325 8,012 37,325 8,005 37,325 8,011
capital
The Trust's issued Ordinary share capital at the beginning of the year
consisted of 31,822,330 Ordinary shares. On 11 June 2012, 4,177 new Ordinary
shares were issued pursuant to the exercise of Subscription shares on 31 May
2012. The subscription price paid per Ordinary share was £9.50 and total
proceeds of £40,000 were received by the Trust.
At the beginning of the year, the Trust had 5,502,368 Subscription shares in
issue. Each Subscription share entitles the holder to subscribe for one
Ordinary share upon exercise of the subscription right and payment of the
subscription price. The next opportunity to exercise subscription rights is on
31 October 2012, at a price of £9.50 per Ordinary share. The final exercise
date is on 31 May 2013 at a subscription price of £10.25 per share.
Whilst the Trust no longer has an authorised share capital, the Directors will
still be limited as to the number of shares they can at any time allot as the
Companies Act 2006 requires that Directors seek authority from the
shareholders for the allotment of new shares. Such authorities were granted by
the shareholders at the 2012 AGM of the Trust; full text of resolutions can be
found on pages 100-101 of the 2011 Annual Report and Accounts.
6. Income
Six months Six months Year
ended ended ended
30.6.12 30.6.11 31.12.11
£'000 £'000 £'000
(unaudited) (unaudited) (audited)
Income from investments held
by HGT LP and HGT 6 LP
UK unquoted investment income 8,949 4,075 4,474
Foreign unquoted investment 3,717 4,938 12,591
income
Gilt interest less amortisation of 84 42 53
premium
Total investment income 12,750 9,055 17,118
Other income
Deposit interest 31 11 23
Other interest income - 20 18
Total other income 31 31 41
Total income 12,781 9,086 17,159
Priority profit share charge
against income
Current year - HGT LP (636) (940) (1,357)
Prior year - HGT LP (402) - -
Current year - HGT 6 LP (2,440) (2,494) (4,914)
Prior year - HGT 6 LP - (1,690) (8,936)
Total priority profit share (3,478) (5,124) (15,207)
charge against income
Total net income 9,303 3,962 1,952
Total net income comprises:
Interest 9,303 3,962 1,952
Total net income 9,303 3,962 1,952
7. Priority profit share and carried interest
(a) Priority profit share payable to General Partners
Revenue return
Six months Six months Year
ended ended ended
30.6.12 30.6.11 31.12.11
£'000 £'000 £'000
(unaudited) (unaudited) (audited)
Priority profit share payable
Current year amount 3,536 3,434 7,190
Less: Current year loans (460) - (919)
advanced to General Partners
Current year charge 3,076 3,434 6,271
against income
Add: Prior year loans to 402 1,690 8,936
General Partners recovered
from priority profit share
Total priority profit share 3,478 5,124 15,207
charge against income
The priority profit share payable on HGT LP, HGT 6 LP and Hg Mercury D LP rank
as a first appropriation of net income from investments held in HGT LP, HGT 6
LP and Hg Mercury D LP respectively and is deducted prior to such income being
attributed to the Trust in its capacity as a Limited Partner. The net income
of HGT LP, HGT 6 LP and Hg Mercury D LP earned during the year, after the
deduction of the priority profit share, is shown on the income statement.
(b) Loans to General Partners
Capital return
Six months Six months Year ended
ended ended 31.12.11
30.6.12 30.6.11 £'000
£'000 £'000 (audited)
(unaudited) (unaudited)
Movements on loans to
General Partners
Losses on current year (460) - (919)
loans advanced to
General Partners
Gains on prior year loans 402 1,690 8,936
to General Partners
recovered against income
Total (losses)/gains on (58) 1,690 8,017
loans recoverable from
priority profit share
due to General Partners
In years in which the funds noted in note 7(a) have not yet earned sufficient
net income to satisfy the priority profit share, the entitlement is carried
forward to the following years. The priority profit share is payable quarterly
in advance, even if insufficient net income has been earned. Where the cash
amount paid exceeds the net income, an interest free loan is advanced to the
general partner by these primary buyout funds, which is funded via a loan from
the Trust. Such loan is only recoverable from the general partner by an
appropriation of net income; until net income is earned, no value is
attributed to this loan and hence an unrealised capital loss is recognised and
reversed if sufficient income is subsequently generated.
(c) Carried interest to Founder Partners
Capital return
Six months Six months Year
ended ended ended
30.6.12 30.6.11 31.12.11
£'000 £'000 £'000
(unaudited) (unaudited) (audited)
Carried interest payable
Current year amount 2,522 2,393 2,079
Total carried interest charge 2,522 2,393 2,079
against capital gains
The carried interest payable ranks as a first appropriation of capital gains
on the investments held in HGT LP, HGT 6 LP and Hg Mercury D LP, limited
partnerships established solely to hold the Trust's investments, and is
deducted prior to such gains being paid to the Trust in its capacity as a
Limited Partner. The net amount of capital gains of HGT LP, HGT 6 LP and Hg
Mercury D LP during the year, after the deduction of carried interest, is
shown on the income statement.
8. Other expenses
Revenue return
Six months Six months Year
ended ended ended
30.6.12 30.6.11 31.12.11
£'000 £'000 £'000
(unaudited) (unaudited) (audited)
Custodian and administration fees 226 206 445
Other administration costs 1,081 12 2,152
1,307 218 2,597
9. Cash flow from operating activities
Six months Six months Year
ended ended ended
30.6.12 30.6.11 31.12.11
£'000 £'000 £'000
(unaudited) (unaudited) (audited)
Reconciliation of net return
before taxation to net cash
flow from operating activities
Net return before taxation 29,282 23,438 723
Add back: (Gains)/losses on (23,866) (20,397) 4,570
investments held at fair value
Increase in carried interest 443 1,257 943
payable
Amortisation of premium on 941 1,288 2,656
government securities
Increase in prepayments (12,048) (1,438) (4,648)
and accrued income
Decrease in debtors - 17 17
Decrease in creditors (19) (925) (495)
Tax on investment income - - (7)
included within gross income
Net cash (outflow)/inflow (5,267) 3,240 3,759
from operating activities
10. Taxation
Tax for the six month period is charged at 26% to 31 March 2012 and 24% from 1
April 2012 (31 December 2011: 26%), representing the best estimate of the
average annual effective tax rate expected for the full year, applied to the
pre-tax income of the six month period.
In the opinion of the Directors, the Trust has complied with the requirements
of Section 1158 and Section 1159 of the CTA 2010 and will therefore be exempt
from corporation tax on any capital gains made in the year. The Trust expects
to designate all of any dividend declared in respect of this financial year as
an interest distribution to its shareholders. This distribution is treated as
a tax deduction against taxable income, resulting in no corporation tax being
payable by the Trust on the interest income designated as a dividend.
11. Return and net asset value per Ordinary share
(a) Return per Ordinary share
Revenue return Capital return
Six months Six months Year Six months Six months Year
ended ended ended ended ended ended
30.6.12 30.6.11 31.12.11 30.6.12 30.6.11 31.12.11
£'000 £'000 £'000 £'000 £'000 £'000
(unaudited) (unaudited) (audited) (unaudited) (unaudited) (audited)
Earnings (£`000):
Return on ordinary 7,661 3,430 (645) 21,286 19,694 1,368
activities after taxation
Number of shares (`000)
Weighted average number 31,823 31,223 31,518 31,823 31,223 31,518
of shares in issue
Return per Ordinary 24.07 10.99 (2.05) 66.89 63.08 4.34
share (pence)
The Trust's issued share capital at the beginning of the year consisted of
31,822,330 Ordinary shares. On 11 June 2012, 4,177 new
Ordinary shares were issued pursuant to the exercise of Subscription shares.
The remaining 5,498,191 Subscription shares may be exercised and new Ordinary
shares issued at the next exercise date on 31 October 2012, or the final
exercise date on 31 May 2013 (see note 5).
(b) Net asset value per share
Six months Six months Year
ended ended ended
30.6.12 30.6.11 31.12.11
£'000 £'000 £'000
(unaudited) (unaudited) (audited)
Net asset value (£'000)
Net assets 372,637 369,018 346,832
Assuming exercise of all 52,233 52,487 52,272
outstanding Subscription
shares
Fully diluted net asset 424,870 421,505 399,104
~value
Number of Ordinary
shares (`000)
Number of Ordinary 31,827 31,800 31,822
shares in issue
Potential issue of new 5,498 5,525 5,503
Ordinary shares on exercise
of Subscription shares
Ordinary shares in issue 37,325 37,325 37,325
following exercise of
Subscription shares
Basic net asset value 1,170.8 1,160.4 1,089.9
per share (pence)
Fully diluted net asset 1,138.3 1,129.3 1,069.3
value per share (pence)
The diluted NAV per share is calculated by adding to the current NAV (basic)
of £372,637,000 the proceeds of £52,233,000 from the exercise of Subscription
shares, assuming all outstanding Subscription shares will be exercised at the
minimum price of £9.50, and then dividing the adjusted NAV (diluted) by the
adjusted number of Ordinary shares in issue (37,324,698).
12. Commitment in fund partnerships
Original and outstanding Original Outstanding
commitments in Fund commitment
partnerships Fund £'000
30.6.12 30.6.11 31.12.11
£'000 £'000 £'000
HGT 6 LP(1) 285,029 78,155 136,426 85,888
HgCapital Mercury LP 60,000 58,454 - 58,970
Hg RPP2 C LP 32,365(2)23,090(3) 27,445 27,222
HGT LP(4) 120,000 14,794 25,210 17,094
HgCapital 6 E LP 15,000 4,113 - 4,732
Hg RPP LP 17,510(5) 452(6) 1,921 1,236
Total outstanding commitments 179,058 191,002 195,142
(1) HgCapital Trust plc has the benefit of an investment opt-out provision in
its commitment to invest alongside HgCapital 6, so that it can opt out of a
new investment without penalty should it not have the cash available to
invest.
(2) Sterling equivalent of €40,000,000
(3) Sterling equivalent of €28,537,000 (30 June 2011: €30,390,000; 31 December
2011: €32,590,000)
(4) With effect from 21 October 2011, £12 million (10% of the original £120
million loan commitment to the Hg5 Fund) was cancelled.
(5) Sterling equivalent of €21,640,088
(6) Sterling equivalent of €559,000 (30 June 2011: €2,127,000; 31 December 2011:
€1,479,000)
13. Publication of non-statutory accounts
The financial information contained in this half-yearly financial report does
not constitute statutory accounts as defined in Section 434 of the Companies
Act 2006. The financial information for the six months ended 30 June 2012 and
30 June 2011 has not been audited. The information for the year ended 31
December 2011 has been extracted from the latest published audited financial
statements, which have been filed with the Registrar of Companies. The report
of the auditors on those accounts contained no qualification or statement
under section 498 (2) or (3) of the Companies Act 2006.
14. Annual results
The Board expects to announce the results for the year ending 31 December 2012
in March 2013. The Annual Report should be available by the end of March 2013,
with the Annual General Meeting being held in May 2013.
BOARD, MANAGEMENT AND ADMINISTRATION
Board of Directors
Roger Mountford (Chairman)
Piers Brooke
Richard Brooman (Chairman of the Audit & Valuation Committee)
Peter Gale (Deputy Chairman and Senior Independent Director)
Andrew Murison
Mark Powell
HgCapital Trust plc
2 More London Riverside
London
SE1 2AP
www.hgcapitaltrust.com
Registered office
(Registered in England No. 1525583)
2 More London Riverside
London
SE1 2AP
Manager
HgCapital*
2 More London Riverside
London
SE1 2AP
Telephone: 020 7089 7888
www.hgcapital.com
Secretary and administrator
Hg Pooled Management Limited**
2 More London Riverside
London
SE1 2AP
Telephone: 020 7089 7888
www.hgcapital.com
Custodian
Hg Investment Managers Limited**
2 More London Riverside
London
SE1 2AP
Registrar
Computershare Investor Services PLC**
The Pavilions
Bridgwater Road
Bristol BS99 6ZZ
Telephone: 0870 702 1037
www-uk.computershare.com/investor
Stockbrokers
Jefferies Hoare Govett**
Vintners Place
68 Upper Thames Street
London EC4V 3BJ
Telephone: 020 7029 8000
www.jefferies.com
Numis Securities Ltd**
The London Stock Exchange Building
10 Paternoster Square
London EC4M 7LT
Telephone: 020 7260 1000
www.numiscorp.com
Independent auditor
Deloitte LLP
2 New Street Square
London EC4A 3BZ
AIC
Association of Investment Companies
www.theaic.co.uk
LPEQ
Listed Private Equity
www.lpeq.com
HgCapital Trust plc is a founder member of LPEQ (formerly iPEIT). LPEQ is a
group of private equity investment trusts and similar vehicles listed on the
London Stock Exchange and other major European stock markets, formed to raise
awareness and increase understanding of what listed private equity is and how
it enables all investors - not just institutions - to invest in private
equity.
LPEQ provides information on private equity in general, and the listed sector
in particular, undertaking and publishing research and working to improve
levels of knowledge about the asset class among investors and their advisers.
*HgCapital is the trading name of Hg Pooled Management Limited and HgCapital
LLP
**Authorised and regulated by the Financial Services Authority.